FUJIFILM Biosciences has announced the commercial launch of BalanCD HEK293 Perfusion A. Designed to expand and augment the company’s portfolio of gene therapy application solutions, BalanCD HEK293 Perfusion A uses suspension HEK293 cells and perfusion technology to provide reliable, efficient, and scalable production of viral vectors for development of gene therapies. HEK293 cells are well established for gene therapy applications in upstream bioprocessing, offering reliable growth rates, high transfection success and expression of cellular factors needed for virus replication. BalanCD HEK293 Perfusion A further enables process optimisation by maximising cell growth, viability, and productivity, and supporting a wide range of applications…

Upperton Pharma Solutions has won the award for Pharma Contract Services Company of the Year at the Pharma Industry Awards UK and nominated finalist for Pharma Company of the Year. This year marks a second year of success at the Pharma Industry Awards, with a win in 2024 for Large Pharma Project of the Year. Now in its third year, the Pharma Industry Awards UK are amongst the most prestigious events in the UK Pharma Calendar. Noting the important role UK Pharma plays globally, each finalist is carefully assessed by an independent panel of experts with expertise ranging from academia…

Cold Chain Technologies (CCT) has developed two digital tools: CCT Route Pro and CCT Lane Risk. Managing temperature-sensitive medications is a daily challenge for specialty pharmacies. Traditionally, teams have relied on static seasonal calendars or manual weather checks to determine how best to package and ship medicines. With varying climates across the U.S., these methods can increase the risk of temperature excursions, add complexity to compliance, and create additional work for staff. CCT Route Pro uses predictive weather data, shipping lane analysis, and destination ZIP codes to recommend the most appropriate pack-out for each shipment. By replacing guesswork with data-driven guidance, it…

Steven Dublin and Joel Eichmann, Green Elephant Biotech, discuss using data to drive innovation and sustainability in biotech. Many biotech companies generate enormous amounts of data, but often struggle to extract actionable insights. Why do you think this is the case? Joel: Generating data is rarely the problem; making it usable is. Biotechs collect information across research, process development, QA, supply chains, and business functions. Yet this information often ends up isolated in different formats—Excel sheets, CRMs, LIMS outputs, or even scanned handwritten reports. Site-to-site differences make it worse. A protocol from one facility may look very different from another,…

eXmoor Pharma, an integrated cell and gene therapy CDMO, has announced a new strategic partnership with Anthony Nolan: Cell Therapy & Laboratory Services (CT&LS), a company in cellular starting materials providing donor material solutions to the cell and gene therapy industry. This collaboration brings together two UK-based advanced therapy organisations. It offers a fully joined-up, ethically and scalable driven solution for developers of autologous and allogeneic cell therapies. Together, eXmoor and Anthony Nolan’s CT&LS will provide an end-to-end service that spans donor sourcing and screening, apheresis collection, process development and GMP manufacturing. The partnership supports clients to move from starting material to clinical supply with…

Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, has announced the appointment of Roland W. Bürli, PhD, as chief scientific officer (CSO). Dr. Bürli brings more than 25 years of experience in drug development and has held senior leadership roles across pharma and biotech companies. He has an extensive track record of advancing preclinical programs from early discovery stages through preclinical development into clinical evaluation. His leadership and scientific expertise span across multiple therapeutic areas, including neurodegenerative diseases, and was instrumental in building R&D organisations as well as securing fundraising in his recent biotech positions. At Scenic,…

Almac Group has completed a multi-million-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK. The significant investment by Almac Pharma Services, will address ongoing industry challenges around solubility and growing global demand for advanced formulation solutions. The investment includes the installation of Buchi S300 and GEA PSD1 closed-loop spray drying technology and extensive expansion of the facility’s analytical laboratories. This new technology, coupled with existing liquid capsule filling and non-sterile oral liquid formulation solutions at the facility, widens Almac’s bioavailability enhancement capability. The new technologies’ containment capabilities also complement existing potent-handling capabilities at the site. This latest…

OQ, an energy investment and development company, and diversified global manufacturer Milliken & Company has announced the introduction of a new clarified random copolymer for injection moulding applications. OQ utilised Milliken’s Millad NX 8000 ECO additive solution to debut its Luban RP2251T injection moulding grade that has a superior aesthetic appearance and can be processed at significantly lower temperatures, enabling converters to generate energy savings and improved productivity due to reduced cycle times. This innovation enables converters to reduce energy consumption and achieve higher productivity, directly contributing to sustainable manufacturing and packaging solutions that meet evolving global needs. “From product development to…

Aenova, a global contract development and manufacturing organisation (CDMO), is expanding its microbiology quality control (QC) laboratory at its Latina site. The project adds approximately 500 square meters of new laboratory space, bringing the total to around 800 square meters, and marks a major milestone in the site’s development. With the implementation of a significantly expanded new QC laboratory, Aenova will gain new and advanced laboratory capabilities. These include sterility testing for biologics using isolator technology, collection and trending of environmental monitoring data, bacterial ID technologies, and advanced techniques for monitoring viable particles, bioburden, and endotoxins. Operational workflows will be…

Steve Gonzales, founder and technical advisor, Technical Safety Services, explores meeting cGMP, ISO, and WHO standards. For many decades, companies have worked diligently to meet regulatory frameworks such as current Good Manufacturing Practice (cGMP), International Organisation for Standardisation (ISO) classifications, and World Health Organisation (WHO) guidelines for cleanrooms. Yet even as science marches onward, the standards continue to get stricter, raising the bar for what counts as being fully compliant. For pharmaceutical manufacturing professionals, the challenge lies in anticipating what’s next and preparing facilities accordingly. A lot is at stake, and it pays to look forward to what might come…

PackworldUSA, a manufacturer of precision heat sealing equipment, will exhibit at the American Association of Tissue Banks (AATB) Annual Meeting, taking place 12-15th October 2025, in Atlanta, GA. Visitors to booth 227 will have the opportunity to explore advanced sealing technologies that combine high At the event, PackworldUSA will showcase its specialised impulse heat sealing equipment engineered to handle the most demanding applications. Capable of sealing at temperatures approaching or exceeding 300°C, these machines are ideally suited for challenging fluoropolymer materials such as FEP, PFA, PTFE, and other specialty films frequently used in tissue and organ packaging. By leveraging industry-leading impulse…

Tim Roberts, chief commercial officer for PCI Pharma Services, explores the current pharmaceutical contract manufacturing landscape. What are the key trends currently shaping the pharmaceutical contract manufacturing landscape? We’re seeing a clear shift toward complex modalities driving demand for specialised capabilities, such as biologics, cell and gene therapies, and targeted therapies like TPDs and ADCs. Supply chain diversification remains critical post-COVID, while regulatory scrutiny around quality and data integrity continues intensifying. Sustainability also has become a key differentiator, with clients evaluating partners on environmental and carbon emissions reduction credentials. How are global supply chain disruptions still affecting contract manufacturers post-COVID?…

Haughton Design, a UK-based product design consultancy specialising in medical devices, drug delivery systems and healthcare technology, has appointed Dr Ash Ghadar as chief executive officer (CEO) to lead the company’s next phase of growth in the medtech and pharmaceutical sectors.  Dr Ghadar joined Haughton Design in January 2025 as director of Strategic Development, where he played a key role in aligning the business with the fast-changing needs of healthcare innovation. His appointment underscores the company’s ambition to expand internationally and strengthen its position as a trusted partner for organisations developing next-generation devices.  With more than 25 years’ experience in product development,…

Alchemab Therapeutics (Alchemab), a biopharmaceutical company which identifies and develops naturally occurring therapeutic antibodies from resilient individuals, has announced initiation of a Phase 1 first-in-human study of ATLX-1282. ATLX-1282 was licensed to Eli Lilly and Company (Lilly) in May 2025 as part of an exclusive global licensing agreement, which included a milestone payment to Alchemab following the initiation of the Phase 1 first-in-human study. Alchemab will conduct the first-in-human study for ATLX-1282 and Lilly will lead further development and commercialisation of the therapy. The Company also announced a $32 million Series A extension financing, bringing the Company’s total Series A…

p36, a provider of digital compliance solutions for the life sciences sector, has announced the official launch of UDI Connect, a next-generation SaaS solution purpose-built for medical device companies who have established robust internal UDI governance – and are now ready to automate, integrate, and scale their compliance across global markets. Bridging the last mile of UDI compliance UDI Connect addresses a persistent gap in UDI processes: while many medtech organisations have invested heavily in robust data validation and internal workflows, the final step, submitting data to regulatory databases such as EUDAMED, GUDID, and others, often remains manual, error-prone, and labor-intensive. “Across…

Bespak, a manufacturer of drug delivery systems, has reaffirmed its commitment to sustainable and responsible business by partnering with Tunley Environmental to complete their inaugural Supply Chain Biodiversity Footprint (SCBF) assessment. This collaboration sets a precedent for sustainability in the pharmaceutical industry, showing how science-based methods can uncover and reduce negative ecological impacts buried deep within complex global supply chains. Why it matters Biodiversity and healthy ecosystems form the backbone of a stable global environment and global economy. All businesses depend on ecosystem services, which are the natural processes and resources that support life and industry (i.e. clean water, soil,…

Informa Markets will once again welcome the global pharmaceutical industry to CPHI Frankfurt 2025, running from 28-30th October at Messe Frankfurt. The three-day event is expected to draw more than 63,000 attendees, with six content theatres, more than 2,000 exhibitors, and a packed programme dedicated to networking and innovation. Celebrating its 36th year, CPHI Frankfurt brings together professionals from across the drug development and manufacturing ecosystem. The event is organised by Informa Markets, a division of Informa, which delivers B2B events across global industries. “CPHI is more than an event, it’s a global experience,” said Tara Dougal, event director, CPHI Frankfurt.…

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced plans to establish a new initiative to advance the safe adoption of agentic AI. The announcement follows research conducted at the Alliance’s European conference that found life science professionals expect agentic AI to be among the most disruptive technologies in the next 2-3 years. The agentic AI project will bring together experts from pharma, biotech and technology companies to shape standards and protocols for AI agents. Initial seed funding has been provided by Genentech, and the Alliance is now seeking additional project…

Aptamer Group, a developer of next-generation synthetic binders delivering innovation to the life science industry, has announced the launch of its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development an innovative approach to identify and validate new disease markers. The service integrates Aptamer’s proprietary Optimer technology with advanced proteomic analysis to provide an unbiased, high-throughput approach to biomarker identification. This methodology represents a significant advancement over traditional discovery approaches by simultaneously identifying biomarkers and generating corresponding affinity ligands, as aptamers. The platform utilises Optimers, which are short, synthetic oligonucleotide molecules with enhanced stability and binding specificity, to differentiate…

HERMA, a manufacturer of precision labelling machines for a variety of sectors, will showcase a quartet of high-performance labelling solutions at Pack Expo Las Vegas, 29th September – 1st October. At Booth N-5370, the company will provide live demonstrations of several modules, including a robotics-enabled labelling cell, a versatile front/back/wrap labelling machine, a medium-batch labeller for autoinjectors, and its latest precision label applicator.  Robotic labelling cell Featuring the market’s smallest fully integrated servo gripper, the HERMA 211R HC robotic labelling cell is specifically designed for small batch sizes and products with complex shapes. Employing optimised robotics, the 211R HC significantly…

Promoted and organised by IMA Active, NEXTEN will be held on 27-28th October 2025 in the setting of Villa Erba, Lake Como in Italy. It will be a world première of the new IMA Active tablet presses and will involve leaders in the pharmaceutical industry through a variety of technical sessions. Attendees from all over the world will have the chance to discover DOMINA and SOLIDA, a brand-new concept of tablet presses, designed to change the meaning of production in the pharmaceutical industry. Conceived as a modular technological platform, where all the functional blocks are easily removable and interchangeable, DOMINA is…

PacBio, a developer of sequencing solutions, has announced that EpiCypher has joined the PacBio Compatible program. The partnership brings EpiCypher’s CUTANA Hia5 enzyme to market for use with Fiber-seq assays on PacBio HiFi sequencing systems, giving researchers a new way to see chromatin biology at single-molecule resolution. Fiber-seq (single-molecule chromatin fibre sequencing) is an advanced multi-omic whole genome sequencing (WGS) assay that simultaneously measures chromatin accessibility, DNA methylation, and DNA variation on individual DNA molecules. Unlike traditional short-read epigenetic assays like ATAC-seq, Fiber-seq using HiFi sequencing reveals the connections between multiple genetic and epigenetic features in a single assay, providing a powerful new approach to…

One2Treat, a technology company transforming how the patient voice is integrated into clinical development, has announced the successful completion of a planned seed extension to accelerate its software platform development. In parallel, One2Treat has relocated to a larger office in Louvain-la-Neuve to support its continued growth. This investment follows the deployment of the One2Treat Insights module across multiple live projects and the recent release of the One2Treat Voice module.  The funding supports the continued development and scaling of One2Treat’s cloud-based software platform. This platform integrates diverse patient-focused outcomes into a single, comprehensive assessment of treatment effects, enabling a clearer understanding of the Net…

Jamil Ahmed, distinguished engineer, Solace looks at Europe’s drug shortage crisis and how to end it with modern integration. 2024 in review: a year of shortages The widespread drug shortages that reached alarming levels in 2024 served as a critical warning for the pharmaceutical industry. From cancer treatments and insulin to ADHD medications and diabetes drugs like semaglutide – patients faced delays, substitutions, and uncertainty. These were not isolated incidents. They exposed a deeper structural weakness: Europe’s pharmaceutical supply chain is still too fragile, too opaque, and too slow to adapt to sudden shocks. As we approach the second half…

Gifthealth has announced its acquisition of Occam Health Services creating the “first-of-its-kind” digital pharmacy platform and patient access hub solution. Gifthealth is a direct-to-patient partner for manufacturers and a pioneer in digital-first brand experiences. Integrating with Occam’s high-touch, personalised model positions the combined company to cut through today’s patient journey. Serving more than six million patients annually across 20 brands – including low-cost therapies at high volumes and lower-volume specialty and rare medicines – Gifthealth + Occam drives new patient access benchmarks: Dispense rates 50% higher than industry averages Refill success 1.5 times national averages Customer satisfaction scores >90%…

The pharmaceutical industry continues to evolve, adopting new technologies and optimising resources and expertise to meet authentication and anti-counterfeiting challenges, says Dr Mark Deakes, chairman of the International Optical Technologies Association (IOTA). Global prescription drug sales are predicted to reach $1.6 trillion by 2028, according to one industry report. Other industry analysis forecasts a CAGR of 6.12% between 2025 and 2030, reaching $2,350.43 billion by 2030. Growth is being driven by increasing global healthcare demands and advancements in obesity, neurological conditions, and cancer treatment among other factors. However, while new technologies propel global advances, the pharmaceutical industry continues to struggle to combat…

Lubrizol will showcase the benefits of its polymer-based excipients for the solubility, bioavailability and palatability of APIs and nutraceuticals at CPHI Frankfurt (28th– 30th October 2025 at Stand 8.0M71). Lubrizol partners with pharmaceutical and nutraceutical companies to develop innovative solutions that improve patient outcomes and offer consumer benefits. Its best-in-class solutions highlighted at CPHI will include: Apisolex Polymer Excipient As the number of poorly soluble APIs grows, many existing excipients are unable to solve all of the complex challenges facing formulators. Apisolex is a polyamino acid-based polymer excipient for injectable and parenteral drug formulations with the potential for creating life-changing therapies. It…

CN Bio, a provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, has announced the expansion of its Contract Research Services (CRS) with new PhysioMimix computational modelling tools. These capabilities have been developed to enhance Absorption, Distribution, Metabolism and Excretion (ADME) profiling, for accelerated drug discovery and development workflows. This launch represents the Company’s new in silico tools available to customers and is designed to enhance data generation from its range of predictive in vitro tools – unlocking deeper insights into key ADME parameters, including human bioavailability, and enabling more confident in vitro to in vivo extrapolation (IVIVE). CN Bio’s computational tools combine the insights gained…

Körber has released the latest version of its PAS-X Manufacturing Execution System. The new PAS-X MES 3.4 has a web-based, scalable platform, intuitive user experience, AI support, and smart tools for deployment, monitoring, and long-term lifecycle management. “With the launch of PAS-X MES 3.4, Körber is setting a new benchmark for digital manufacturing in the life sciences industry,” states Pierrick Lebigre, vice president product software, Körber Business Area Pharma. “Our customers gain a powerful cloud- and AI-driven platform that modernises the shopfloor and makes processes faster, more flexible, and more efficient. This release lays the foundation for sustainable competitiveness in a…

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered imaging and clinical data curation platform, has announced the appointment of Craig Rhodes as head of partnerships to lead strategic engagements with pharmaceutical organisations, in line with Qureight’s revenue growth targets.  Rhodes was formerly EMEA director of healthcare and life sciences at NVIDIA. In his new role, Rhodes will lead on securing and managing strategic relationships with pharma partner organisations, from conception through to delivery. Leveraging his deep expertise in technology integration and relationship development, Rhodes will support the adoption and integration of the Qureight…

Cold Chain Technologies (CCT), has reinforced its commitment to expanding its Asia Pacific (APAC) presence with a series of investments and partnerships. Expanding on its strong base in the region, the latest moves are designed to leverage CCT’s global knowledge and local capabilities to better support pharmaceutical, airline and 3PL customers with their temperature-controlled logistics. “Following the acquisition of Tower Cold Chain and GCCS – both of which had a strong presence and reputation in APAC – we are building new partnerships and networks to ensure customers globally can access our range of passive parcel and pallet shippers quickly and…

Aptamer Group, a developer of next-generation synthetic binders delivering innovation to the life science industry, has announced the launch of its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development an approach to identify and validate new disease markers. Technical Innovation delivers novel biomarker discovery approach The service integrates Aptamer’s proprietary Optimer technology with advanced proteomic analysis to provide an unbiased, high-throughput approach to biomarker identification. This methodology represents a significant advancement over traditional discovery approaches by simultaneously identifying biomarkers and generating corresponding affinity ligands, as aptamers. The platform utilises Optimers, which are short, synthetic oligonucleotide molecules with enhanced…

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered imaging and clinical data curation platform, has announced that it has been selected by Calluna Pharma to support its Phase 2 AURORA study. Qureight will analyse imaging data from adult patients, evaluating anatomical lung changes in individuals treated with CAL101, Calluna’s lead asset for the treatment of idiopathic pulmonary fibrosis (IPF). Steven Bishop, chief data officer, Qureight, said: “We’re delighted that Calluna has chosen to work with us on this next stage of clinical trial for their lead programme. Our deep learning imaging technology is…

SGD Pharma, a provider of pharmaceutical glass packaging, has announced an agreement with Italian Private Equity firm Entangled Capital to acquire Alphial S.r.l, a producer of Tubular Vials and Ampoules headquartered in Italy. This strategic acquisition will enhance SGD Pharma capabilities and expand our market presence in Europe. Alphial S.r.l. is a tubular glass converting company manufacturing ampoules, vials and Ready To Use (RTU) products. The Company employs more than 220 people across four manufacturing sites in Italy. This acquisition will constitute another step in the implementation of our strategy to reinforce our tubular glass manufacturing presence globally.  Two years ago, SGD…

Veeva Systems has announced a collaboration with Amgen to advance clinical trial innovation. As a global leader in biotechnology, Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process, building on the company’s commitment to accelerating the development of new medicines for patients with serious diseases. “In collaboration with Veeva, we’re leveraging advanced technology to unlock new capabilities for our end-to-end trial operations which are expected to further strengthen our ability to bring innovative treatments to patients with speed and scale,” said Scott Skellenger, senior vice president and chief information officer at Amgen. “We’re excited to…

Dr. Subhashis Chakraborty, general manager, head – global product management at ACG Capsules discusses the European Commission’s decision on titanium dioxide in pharmaceuticals. 1. What does the European Commission’s decision mean in practical terms for pharmaceutical manufacturers in Europe? The Commission’s decision to maintain the use of titanium dioxide (TiO₂) in medicines, based on EMA’s April 2024 Over the past two years, companies had already started exploring TiO₂-free options for new products. But the real challenge was always the existing portfolio, around 91,000 human and 1,600 veterinary medicines in the EU, where TiO₂ serves not just as a colourant, but as…

Rotzinger PharmaPack is launching a new filling and capping platform for over-the-counter (OTC) products such as non-aseptic pharmaceuticals as well as solid and liquid products from the cosmetics, personal care, and nutraceutical industries. VarioFill combines the advantages of previously large lines on a compact and modular platform. “Where manufacturers and contract fillers previously needed new machines for different products and closures, VarioFill now enables them to process everything on a single platform – from non-aseptic pharmaceutical liquids such as eye drops and cough syrup to cosmetics such as creams and face serums to solid dosage forms such as tablets and capsules.…

Continuous Process Solutions has won a regional business awards programme. Continuous Process Solutions, based in Dudley, UK, offers a tailored range of high-performance, high-strength steel conveyor belts, machinery, equipment and technical support for the pharmaceutical industry, as well as for rubber, plastics and wood-based panel production. The business has now been named Best Steel Conveyor Solutions Company in the 2025 Midlands Enterprise Awards. Organised by business magazine SME News and now in its seventh year, this is an awards programme which showcases the achievements of businesses operating in the dynamic Midlands region. The awards are given solely on merit and are awarded…

Tasso, a company in patient-centric blood collection, and SheMed, a UK-based women’s healthcare company, have teamed up to deliver safer, more personalised weight loss treatments through convenient at-home diagnostics. SheMed’s patient-friendly testing program, which integrates the Tasso+ blood collection device, ensures that every patient completes a comprehensive lab screening before starting GLP-1 treatment, all from the comfort of home. The program has already treated thousands of women across the UK.  For decades, women have been underrepresented in clinical trials. As a result, many treatments have been developed based on male physiology, leading to a one-size-fits-all approach that often overlooks women’s specific…

Cartherics, a biotech company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, has announced the granting of a patent for ‘Method for Providing Immune Cells with Enhanced Function’ by the Chinese Patent Office. This patent covers induced pluripotent stem cells (iPSCs) with a specific gene knock out of the adenosine A2A receptor (A2AR). This receptor is critical for inhibiting immune cell function in the tumour microenvironment of solid tumours. Adenosine, which is found in high levels in solid tumours, suppresses the activity of immune cells like natural killer (NK) cells.…

Scenic Biotech, a pioneer in modifier therapies for severe diseases, has announced a license and research agreement with Alnylam Pharmaceuticals to leverage Scenic’s Cell-Seq platform for discovering novel targets for RNAi therapeutics. “Collaborating with the leading innovator in RNAi therapeutics represents significant validation of our Cell-Seq platform’s unique ability to connect cellular pathways to actionable drug targets,” said Vincent Blomen, PhD, senior director of discovery sciences at Scenic Biotech. “As we advance our pipeline of first-in-class disease-modifying therapies, we’re committed to empowering our partners in developing innovative medicines for patients facing devastating conditions.” This collaboration marks Scenic’s third Cell-Seq collaboration with major…

Er-Kim, an international pharmaceutical company specialising in the commercialisation of novel therapies, has announced a distribution agreement with CNX Therapeutics to supply selected oncology products across Central & Eastern Europe (CEE) and Türkiye. The agreement creates an exclusive partnership for a portfolio of oncology-related medications – including CNX Therapeutics’ Cardioxane (dexrazoxane) and Savene (dexrazoxane) – that are part of CNX’s established oncology portfolio. Through this partnership, treatments will now be distributed across all CEE markets. “A trusted partner and dedicated provider of oncology treatments in the region, Er-Kim has been bringing innovative oncology-related medications to emerging EMEA for 40 plus years, and we are…

Abacus Medicine Group has acquired Swiss Cardio Technologies. The company was founded by a group of cardiovascular surgery specialists with origins at the University of Berne, Switzerland, and are the innovators of Cardioplexol (magnesium sulfate heptahydrate, potassium chloride, xylitol, procaine hydrochloride). The acquisition includes the global rights for Swiss Cardio Technology’s cardioplegia business. Cardioplegia is a technique used to intentionally and temporarily interrupt cardiac activity to facilitate bypass surgery or other cardiac and aortic repairs that require an immobile heart. Flemming Wagner, CEO and founder of the Abacus Medicine Group, said: “Swiss Cardio Technologies exemplifies excellence in healthcare innovation. The opportunities…

Biotech Fluidics has expanded its range of barbed peristaltic tube connectors, designed to securely hold flexible tubing in place. The latest addition to the range is a peristaltic tubing stop adapter that eliminates the need for fixed stoppers and allows custom cut lengths of peristaltic tubing to be installed on any pump head size. This unique adapter allows peristaltic tubing to be simply pressed over a specially designed nose and then held tightly in place by a retainer sleeve. Magda Nystrom, product specialist at Biotech Fluidics said: “Our peristaltic tube connectors are ideal for making reliable, secure connections with soft-walled, peristaltic tubing. We offer a…

Santhera Pharmaceuticals announced the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE (vamorolone) in the United Arab Emirates, the Kingdom of Saudi Arabia, Kuwait, Oman and Bahrain, for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older.  Sales are expected to begin on a named patient basis in Q1 2026, with broader commercial sales anticipated in late 2026 following market authorisation and pricing agreement. Santhera will receive a percentage of net sales as payment, consistent with the company’s previous distribution agreements. This agreement will help ensure that patients across these countries…

The UK government’s industrial strategy aims to strengthen economic growth by focusing on foundational sectors, supply chain resilience, clean energy and the skills needed for a modern workforce. The Institution of Chemical Engineers (IChemE) welcomes many of the commitments but has highlighted areas where more clarity and action will be required to ensure it delivers long-term benefits for industry and society. Here, Duncan Lugton, head of Policy & Impact, analyses the strategy.   A significant aspect of the strategy is the government’s recognition of foundational industries, such as chemicals, which underpin progress in multiple priority growth areas including advanced manufacturing, clean…

Asymchem, a company in contract development and manufacturing (CDMO) solutions, has announced an expansion of its flow chemistry capabilities at its Sandwich, UK facility. This milestone marks the first deployment of Asymchem’s proprietary and CE marking flow equipment in the Western market that further strengthens the company’s position in the adoption of advanced flow chemistry technologies. The newly commissioned suite includes several lab-scale flow equipment and modules designed to enable a wide array of advanced continuous manufacturing processes. Key platforms now operational at the Sandwich site include plug flow reactors (supporting both low and high temperature applications), a heterogeneous hydrogenation…

Nemera relies on Mitutoyo measurement and inspection solutions to ensure its health-critical dispensers, inhalers and pens deliver the exact specified amount of active ingredient. Among recent additions to the Neuenburg facility is a high-resolution computed tomography (CT) system from RX Solutions, a Mitutoyo partner company. This advanced CT system is serving as a further aid to the precision manufacture of drug delivery systems required to treat conditions and diseases that include glaucoma, asthma, psoriasis and diabetes. With almost 700 employees and a production area covering around 11,000 m² across 13 halls, the Neuenburg site is Nemera’s largest. Each year, over…

KNAPP will present its range of solutions for the sector on its stand (F20) at The Pharmacy Show, which takes place on 12-13th October at the NEC in Birmingham. A high-tech partner in the healthcare sector for over 70 years, KNAPP provides solutions from pallet to pill – that is, for the entire value chain, from production and wholesale to the patient. The company will explain its key solutions to show visitors, including its Pack2Patient system for central dispensing automation, its D3 Daily Dose Dispenser for automated compliance pack production and its Central Belt System for automated picking. Central dispensing automation The Pack2Patient solution from KNAPP…

Auto-injectors and pens enable patients to self-administer medication safely. These modern application systems replace visits to the doctor and reduce the burden on the healthcare system. However, this also increases the need for secondary packaging that combines protection, functionality and user-friendliness. Faller Packaging develops sustainable and customisable solutions to achieve this.  New active ingredients for weight reduction mark a turning point in obesity therapy. They can be applied conveniently with auto-injectors or pens, even in weekly doses. This makes the procedure easier for patients, encouraging them to inject the medication themselves at home. Manufacturers therefore need to rethink not only…

The Hosokawa Micron Group and its subsidiaries will be presenting their range of products and services in Hall 11, Stand 137 at Powtech Technopharm 2025 in Nuremberg from 23 – 25th September. Under the motto “Road to Innovation: Turnkey solutions by Hosokawa Micron”, the focus of the trade fair presentation is on the complete solutions for powder processing from the special machine construction group. Hosokawa Alpine also has two new grinders in its portfolio. Powder processing systems from a single source Thanks to the various subsidiaries represented worldwide, Hosokawa Micron Group customers receive turnkey systems for powder processing. Hosokawa Solids (Germany/Spain)…

The last two decades have seen single-use technologies (SUTs) move from niche innovation to the backbone of modern biopharmaceutical manufacturing. Their ability to enable rapid changeovers between production runs, combined with the elimination of cross-batch contamination, and reduced capital requirements, has transformed how we produce biologics, vaccines, and advanced therapies. Yet, behind these operational gains lies a challenge that is quickly becoming a defining test for our industry: how do we maintain the benefits of single-use while reducing the environmental burden they create?  The turning point for sustainability in bioprocessing  Until recently, discussions about SUTs and sustainability were often confined…

Glatt Ingenieurtechnik will be presenting integrated concepts combining particle design, process expertise, process and plant engineering and factory planning at POWTECH TECHNOPHARM in Nuremberg from 23 – 25th September 2025. Energy costs are not only decisive for the final product costs in energy-intensive processes. Glatt Engineering therefore focuses on energy and CO2 savings through energy-optimised concepts for powder synthesis, fluidised bed and spouted bed technology. These include practical options for heat recovery from process exhaust air, HVAC (heating, ventilation, air conditioning), nozzle air generation, product streams or reaction heat. There are many potential savings, and the engineering experts can show how…

The surface cleanliness required for medical and pharmaceutical products is generally achieved during manufacture using liquid-based cleaning processes that consume enormous amounts of energy and water. In order to effectively reduce resource consumption, a joint project funded by Invest BW and involving industrial partners, Fraunhofer IPA and the Natural and Medical Sciences Institute at the University of Tübingen investigated the material compatibility of the dry quattroClean snow jet cleaning technology on product surfaces typically found in the pharma sector. The results of the tests, which included in-vitro cytotoxicity tests as well as VOC and SVOC analyses, prove the suitability of the…

Vicki Pearson, strategic marketing manager at Schneider Electric, discusses how modern environmental monitoring and compliance systems help life sciences firms meet regulatory demands while improving efficiency and security. Today’s industries are increasingly competitive and regulated. Life science companies stake their reputations on their ability to provide regulators with data-intensive, assured, high-credibility reporting. Traceability of critical environmental variables like temperature, pressure, humidity, and organic and non-organic contaminates help validate the integrity and safety of life science manufacturing processes. This is the case from the raw materials phase to the finished and packaged goods phases. When firms submit incomplete or flawed environmental…

Guillaume Gigon, VP of technology and AI, and Robert Taylor, associate director, clinical operations – process improvement, at Indero, explore how Lean Six Sigma (LSS) principles – minimising waste, standardising workflows, and driving improvement through data – are being adapted from manufacturing industries to deliver clinical trials faster, more efficiently, and with greater consistency.  The past few years have been turbulent times for the pharmaceutical industry, especially in the clinical trials sector. Factors such as reduced investment and a lack of public trust have made it particularly challenging for small and medium-sized biotechs to get efficient trials off the ground.…

Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO), has been awarded a grant as part of the first VaxHub Sustainable Platform Funding Call, in collaboration with the University of Oxford. The funding supports the development of an oral formulation for Adenovirus-vectored vaccines.  The project, led by Professor Dame Sarah Gilbert at the University of Oxford’s Pandemic Sciences Institute, aims to address the limitations of intramuscular vaccine administration. By exploring oral delivery routes, the team seeks to induce mucosal immunity, improve vaccine stability, simplify distribution, and support self-administration.  Upperton will apply its expertise in oral dosage form development,…

Rob Abbenhuis, global head, corporate EHS and ESG, Ardena shares a risk-based approach to safe and efficient synthesis of HPAPIs. In recent years, drug discovery has seen a significant drive towards developing highly potent compounds, particularly in critical therapeutic areas like oncology, inflammatory diseases and antiviral treatments. These highly potent active pharmaceutical ingredients (HPAPIs) offer the promise of effective therapies, often at very low doses, but they come with a unique set of challenges.  While HPAPIs hold immense potential, their development in early stages is complicated by limited safety data and often unknown toxicology profiles. This inherent uncertainty means that…

Bionova Scientific, a full-service biologics contract development and manufacturing organisation (CDMO) and subsidiary of global conglomerate Asahi Kasei, has announced the opening of a 10,000 square-foot plasmid DNA (pDNA) development and production facility in The Woodlands, Texas. Located less than 30 miles north of Houston, Texas, the new facility designs, develops and manufactures research-grade pDNA materials to support the cell and gene therapy field. With the global pharmaceutical market anticipated to reach almost $3 trillion by 2033, Bionova Scientific has positioned itself to effortlessly accommodate the market’s rapid growth. Enabled by the new Texas facility, the company will expand its…

Henniker Plasma, a manufacturer of plasma treatment systems, has announced the launch of its Stratus Plasma Manufacturing Cell range — a fully integrated, turnkey solution that combines advanced atmospheric plasma surface treatment with robotic automation.  The Stratus systems are designed to deliver high-speed, high-precision surface activation and cleaning for a broad range of materials and applications. From automotive and aerospace to medical device manufacturing, electronics, and battery technology, Stratus unlocks new efficiencies in production environments that demand repeatable and reliable results.  “The Stratus range reflects our commitment to developing practical, plug-and-play plasma solutions that integrate seamlessly into real-world manufacturing workflows,” said…

Brian Meyer, VP-Sales, PSB Industries discusses the past, present, and future of gas processing technology. The gas processing industry has long played a pivotal role in refining natural gas to ensure its usability for industrial, commercial, and energy applications. This article delves into the evolution of gas processing technologies, exploring early challenges, key advancements, and the future of the field. By understanding these developments, consumers and industry professionals alike can better appreciate the innovations driving efficiency and sustainability in this critical sector.  The early challenges of gas processing  Natural gas in its raw form often contains impurities such as moisture,…

Coveris, European packaging manufacturers, has launched its new website at www.coveris.com, unveiling a fully restructured digital platform designed to maximise visibility, performance and user experience.  The new website reflects the strategic transformation to improve customer experience and responsiveness across all markets. By combining enhanced digital systems, intelligent automation, and a streamlined user interface, the platform enables faster, easier access to Coveris’ full range of over 140 products and services.  Enhanced product visibility through intelligent structure and search  At the heart of the new website is an advanced Product Finder that enables customers to efficiently navigate Coveris’ extensive offering and quickly…

Orbia Fluor & Energy Materials’ pharmaceutical business unit has published a new whitepaper about the industry’s ongoing transition to pressurised metered dose inhalers (pMDIs) to low global warming potential (Low-GWP) propellants. A leader in the development, manufacture and supply of fluoroproducts Orbia Fluor & Energy Materials (Orbia) has published new research outlining the regulatory environment needed to transition successfully to low-GWP medical propellants for pressurised metered dose inhalers (pMDIs). The whitepaper, developed in partnership with DLRC Group, focuses on guidance that can support switching propellant for existing medical products. A 2021 study in the BMJ Open Respiratory Research journal found that switching to pMDIs containing low-GWP propellants…

Guardtech Group design manager Jack Burrow explains how the Suffolk-based cleanroom construction experts are embracing new technology and methodologies to take their project provision to new heights. When it comes to continuous improvement, the Guardtech Group are always open to new ideas. Whether that’s embracing new software, utilising new technology or implementing new practices on and off site, the Haverhill-based contamination control specialists pride themselves on being malleable, open to change and committed to evaluating and improving their process as much as possible.  The Guardtech Group Design Team are no different. Whether it’s a facility for large-scale turnkey brand Cleanroom…

As the UK enters a late summer heatwave, energy solutions, compressed air and temperature control specialist Aggreko has issued a warning that pharmaceutical manufacturers may face reduced efficiency and an increased risk of failure for air compressors. Yellow and amber heat health alerts have been issued across England, with temperatures set to climb above 30°C in some places. With this marking the fourth heatwave of the summer, Russell Brown, product manager – Oil Free Air at Aggreko, is warning that this may significantly impact compressor performance across the face of UK industry. Brown said: “The reality is, current compressed air…

IMCD N.V., a partner for the distribution and formulation of speciality chemicals and ingredients, has received improved ratings from two rating agencies: ISS ESG and Sustainalytics. These upgrades reflect the company’s ongoing progress across key environmental, social and governance (ESG) areas. The recognition follows IMCD’s EcoVadis Platinum medal earlier this year, placing the company in the top 1% of all organisations assessed worldwide for sustainability performance. ISS ESG rating upgraded to B- IMCD’s ESG Corporate Rating from ISS ESG has been raised to B- (from C+), positioning the company above the industry average. The rating reflects strong performance in managing ESG-related risks and…

As part of its strategic transformation into a CDMO (Contract Development and Manufacturing Organisation) for medical devices and complex pharmaceutical drug delivery systems, Sanner announces a management change.  As part of its focus on the CDMO sector, the Sanner Group will now draw even more specifically on expertise from the pharmaceutical industry, both operationally and at management level. Accordingly, the CEO Dr. Johannis Willem van Vliet will leave the company shortly.  Until the new CEO takes office in autumn 2025, Heino Lennartz will take over as interim CEO. He has extensive knowledge in the pharmaceutical and CDMO sectors and as…

PAPACKS, a Germany-based manufacturer of sustainable, moulded-fibre packaging solutions, will introduce its Fiber-Bottle to the North American marketplace at Pack Expo Las Vegas, 29th September – 1st October. At Booth #N-5172, the company will be showcasing its new plastic-free, fully recyclable packaging solution, which is suitable for replacing traditional plastic containers in a wide variety of product applications.   Unlike hybrid fibre-plastic solutions, Fiber-Bottle does not require plastic linings, caps or closures, making it recyclable in common paper waste streams. The result is a full-lifespan CO2 reduction of up to 90% compared with conventional PET or HDPE bottles.  Moulded as one piece,…

Europa Road is playing a vital role in global healthcare by delivering time-critical medical testing kits, which are then distributed to clinics across Asia, Africa, Europe, and the UK.  As part of one of Britain’s largest independent logistics providers, Europa Worldwide Group, Europa Road is supporting a medical technology company that specialises in women’s health, to transport medical testing equipment, including HIV, HPV, Hepatitis B & C, as well as urine and swab sample collection kits.   Ben Sindel, Manchester branch manager, said: “We have been shipping the medical testing kits for nearly a year, using our Delivered at Place (DAP)…

Andreas Koppitz, CEO of pharma packaging at MM Packaging discusses pharma packaging supply chains and the lessons driving change in 2025 and beyond.  1. What key lessons from 2024 are now driving the most meaningful changes in pharma packaging supply chains in 2025?   The past year was marked by continued global uncertainty, which tested the resilience of supply chains across industries — and pharma was no exception.   For packaging, 2024 served as a turning point, highlighting the importance of flexibility, partnership, and strategic alignment. In 2025, these lessons are reshaping how the industry approaches supply chain management:  Resilience through diversification…

UST, a digital transformation solutions company, has partnered with ThinkBio.Ai, an AI-powered solutions provider for biopharmaceutical and healthcare organisations. This strategic partnership will empower UST to more efficiently leverage its expertise in digital transformation and advanced solutions to complement ThinkBio.Ai’s innovative AI-powered R&D capabilities. Together, the companies will deliver transformative solutions that accelerate AI transformation journeys and improve outcomes for biopharma and healthcare organisations worldwide. Leveraging advanced in-house expertise in oncology, immunology, neurology, and cardiology, ThinkBio.Ai has developed a suite of AI-powered solutions to address critical challenges across pharma and biotech preclinical and clinical R&D pipelines. These include data-driven strategies to identify the most…

Polpharma Biologics announces a global (except for Middle East & North Africa) licensing agreement with Fresenius Kabi for the commercialisation of PB016, a proposed biosimilar to vedolizumab, an integrin receptor antagonist, a biologic therapy indicated for moderate to severe ulcerative colitis and Crohn’s disease.  Under the terms of the agreement, Polpharma Biologics will lead development and manufacturing of PB016, while Fresenius Kabi will hold exclusive commercialisation rights worldwide, excluding Middle East & North Africa.   “This partnership reinforces our mission to broaden access to high-quality biologics that improve patient outcomes globally,” said Konstantin Matentzoglu, supervisory board member of Polpharma Biologics Group. “Fresenius Kabi’s deep…

Sanome has secured Class IIb CE certification and MHRA approval for MEMORI, an AI-enabled warning system for the early prediction/prevention of healthcare‑associated infections (HAIs), at the same time as appointing new strategic advisors, including former Health Minister Lord James Bethell and ex-executive director of National Institute for Health and Care Excellence (NICE), Prof Carole Longson. HAIs are a major threat to patient safety. In the US and Europe, HAIs account for $28.4-45 billion and €13-24 billion in healthcare spending respectively. In the UK ,the picture is also stark, costing the NHS around £2.7 billion, with HAIs responsible for an additional 7 million hospital…

Steriline will exhibit for the second consecutive year at Pharma Pro&Pack Expo, an important trade show in India dedicated to machinery for the treatment and packaging of products in the pharmaceutical and biotechnological sectors at stand H6-D45.  Steriline, which has been present in India directly with its own subsidiary since 2022, considers the Indian and Asian market to be very important for its growth and continuously focuses on developing dedicated solutions that meet the needs of the local pharmaceutical industry, while working towards a more sustainable future. The Indian headquarters of Steriline is growing and has nearly doubled the number…

In this article, Sian Gill, managing partner at leading full-service IP firm Venner Shipley, explores the acceleration of the global pharmaceuticals sector and explains why protecting IP is essential to maximising its long-term growth.  It’s safe to say that pharmaceuticals is big business. Recent insight suggests that the market is already worth in excess of $1.7 trillion, with a CAGR of 6.1% taking it to a value surpassing $2.3 trillion by 2030. An aging population, rising demand for specialist healthcare and the drive towards personalised medicines are collectively fuelling insatiable drug demand, while the growth of biotech-based drugs, also known as…

After Identiv announced it’s partnership with Novanta to streamline adoption of RFID solutions for healthcare and medical device OEMs, European Pharmaceutical Manufacturer spoke to Deepak Prakash, vice president of healthcare at Identiv. 1. What specific market gaps or customer pain points are you addressing through the partnership with Novanta?  Identiv and Novanta are partnering to provide medical device manufacturers with access to the most advanced, integrated solutions available. By providing medical device OEMs with streamlined intelligent, RFID-enabled technology, the partnership will enhance patient safety and hospital compliance across the value chain.   2. How will Identiv’s RFID and IoT technologies integrate into…

Solids handling equipment maker, Ajax Equipment, has supplied research instrumentation producer, IGI Systems, with a stainless steel conical hopper with gas purge capability, as part of a prototype Sublimation System for a Low-Pressure Chemical Vapour Deposition application. The hopper includes a variety of features to ensure best performance including manufacture in stainless steel to provide excellent corrosion resistance, while the hopper’s highly polished internal surfaces enhance wall slip which promotes material flow. An external vibrator provides a further aid for flow should it be required. “It was a pleasure to work with Ajax. Their eagerness to engage with our needs…

ESTEVE acquires Regis Technologies, a United States-based Contract Development and Manufacturing Organisation (CDMO), headquartered in Chicago.      This strategic move allows ESTEVE CDMO (actively operating under the Esteve Química brand) a physical presence in the United States, expanding its contract development and manufacturing solutions for innovative small-molecule active pharmaceutical ingredients (APIs) across the entire drug development lifecycle from pre-clinical to commercial manufacturing.    “We are proud to strengthen our CDMO solutions for pharmaceutical innovators through this acquisition, while welcoming around 70 skilled professionals to our US team”, said Joan Petit, chief industrial operations officer of ESTEVE and general manager of Esteve CDMO…

Christine Gottschalk, head of PI Test and Demo Centre, Mettler-Toledo Product Inspection, explores why more pharmaceutical businesses are turning to rental options as a smart, strategic choice. Production lines don’t pause for procurement. When pharmaceutical manufacturers face a sudden spike in demand, new quality control requirements or equipment failure, delays in sourcing inspection systems can lead to costly setbacks. Renting product inspection technology offers a rapid, low-risk way to respond – whether it’s for bridging gaps in delivery, managing seasonal peaks or testing new solutions before purchase.  Meeting urgent quality control demands without capital outlay  Whether facing an unexpected increase…

Titian Software and Labguru have rebranded as Cenevo, bringing together the two companies’ solutions, Labguru and Mosaic, under a new, unified brand, to enable further innovation and increased collaboration to accelerate scientific discovery. The combined organisation specialises in lab management systems, automation, orchestration, data management and AI technology. Cenevo software enables smart connected labs that are automated, data-centric and AI enabled, by combining Mosaic’s sample-centric lab operations with Labguru’s experimental-centric inventory, registration, ELN and LIMS technology. By doing so, scientists can more easily streamline lab operations, prevent data loss, and maximise efficiency and accuracy of research results, empowering them to do more…

Vidir Solutions, a North American manufacturer of automated storage and retrieval systems, announces the Vidir VLM Mini, a compact vertical lift module (VLM) tailored for medical, pharmacy, and laboratory facilities. With a sub-10-foot height and a minimal footprint, the VLM Mini enables facilities to reclaim up to 85% of floor space previously occupied by conventional shelving, ideal for pharmacies, clinics, and labs with low ceilings or tight layouts. The system is engineered for lightweight storage, making it ideal for organising frequently accessed items with automated, secure, and easily accessible storage. Its unique dual-tower design with a central vertical elevator presents…

ESTEVE acquires Regis Technologies, a United States-based Contract Development and Manufacturing Organisation (CDMO), headquartered in Chicago.  This strategic move allows ESTEVE CDMO (actively operating under the Esteve Química brand) a physical presence in the United States, expanding its contract development and manufacturing solutions for innovative small-molecule active pharmaceutical ingredients (APIs) across the entire drug development lifecycle from pre-clinical to commercial manufacturing.  For over 65 years, Regis Technologies has been a US-based API CDMO, offering a broad spectrum of services, including process research & development, analytical & stability, cGMP API manufacturing, CMC support, and a variety of chromatography products. “We are proud…

Norwalt, a specialist in custom-built automation and line integration machinery for complex manufacturing applications, announces its strategic partnership with ei3, a specialist in industrial Internet of Things (IIoT) solutions. Together, the companies have launched Norwalt Nexus, a powerful, AI-driven digital platform designed to transform conventional manufacturing equipment into intelligent, proactive systems.  The Nexus platform, now being integrated across Norwalt’s automation systems, addresses the growing talent crisis and increasing demand for smart, data-driven manufacturing. As manufacturers face over 500,000 unfilled positions in the U.S. and accelerating pressures to implement Industry 4.0 – particularly in regulated industries where compliance and traceability are…

The UK government’s plan to nearly double annual investment in advanced manufacturing means leaders face unprecedented pressure to scale rapidly while maintaining operational excellence. Nick Petschek, managing director EMEA, Kotter International discusses. Though significant funding creates opportunity, the looming ambiguity around implementation timelines, sector prioritisation, and workforce implications will take its toll on organisations across the UK’s pharmaceutical manufacturing landscape if they fail to embrace adaptability and change management strategies.    There are several strategies leaders can adopt to ensure they handle rapid growth without losing operational effectiveness or cultural cohesion.   Why engaged teams drive industrial growth   Research shows that businesses experiencing high…

Almac Group has announced the official opening of new GMP-qualified analytical stability chambers and office space at its US Headquarter campus in Souderton, Pennsylvania. This $2 million investment builds on the multi-million-dollar expansion of global analytical services and reinforces Almac’s commitment to meeting growing client demand.  The new facility includes 1,600 ft² of dedicated stability chamber space and an additional 1,600 ft² of modern office accommodation / laboratory space. The chambers are fully GMP-qualified and equipped with alarmed and redundant systems and utilities, supporting all standard ICH and custom stability conditions including: -20°C, 5°C, 25°C/60%RH, 30°C/65%RH, 30°C/75%RH, and 40°C/75%RH.  This…

Eramol, a UK-based pharmaceutical contract development and manufacturing organisation (CDMO), has announced progress on its new sterile manufacturing facility, scheduled to open in early 2026.   Located in Sevenoaks, Kent, the facility spans 11,000 square feet, including a dedicated 1,900 square foot GMP Grade A/C cleanroom suite designed for small to medium batch production of sterile injectable products. The site will also include modern offices and client reception areas — making it a fully integrated, client-ready environment.  Eramol’s facility is purpose-built to meet the stringent requirements of the 2023 EU GMP Annex 1, incorporating industry best practices to proactively identify, control, and…

John Cogan, COO, Qinecsa outlines the opportunity presented by AI-driven automation to transform pharmacovigilance, both to address soaring workloads and costs, and to inject new strategic purpose into the function’s role. Pharmacovigilance (PV), and most notably its core task of tracking and processing adverse events (AEs), is both essential for regulatory compliance and a huge and costly drain on resources. It monopolises scientists’ time while adding very little value beyond fulfilling authority expectations and managing risk. In the context of long-established drugs, this laborious work feels much like a tick-box exercise. It makes sense then to streamline or outsource processes wherever…

Camgenium has announced its partnership with Professor Petre Cristian Ilie, Consultant Urological and Robotic Surgeon at NNUH NHS Foundation Trust, to develop HealthiumPro, a cloud-based innovative software solution. The system has the potential to improve the outcomes of prostate cancer patients by enhancing safety before and after surgery.  Prostate cancer is the most commonly diagnosed cancer in men in the UK, with 55,000 cases diagnosed annually. Its rate of incidence is expected to increase by 15% between 2023 and 2040. Many men with prostate cancer report having unmet psychosocial, psychosexual and informational needs so enhanced clinical support is crucial, particularly for…

Tiffany Overstreet, innovation director at MM Pharma & Healthcare Packaging, shares the power of innovation in pharmaceutical secondary packaging. Innovation in pharmaceutical secondary packaging is so much more than a competitive advantage – in today’s market, it is a vital tool for supporting sustainability and securing optimal patient outcomes. As the industry faces mounting regulatory pressure, supply chain volatility, and shifting patient and societal expectations, utilising the latest innovations is now central to ensuring product integrity, regulatory compliance, and brand trust.   Why innovation matters now  The pharmaceutical sector is navigating a period of volatility and change. Regulatory frameworks are tightening…

Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova virus removal filters in Nobeoka City, Miyazaki, Japan. The new facility will be the company’s fourth spinning plant for hollow-fibre cellulose membrane filters. Construction is scheduled to begin in July 2026, with operations starting in January 2030. The initiative, backed by a grant from Japan’s Ministry of Economy, Trade, and Industry (METI), aligns with Asahi Kasei’s recently announced medium-term management plan “Trailblaze Together,” which positions the Life Science business as a key driver of future growth. According to a report…

Delphine Perridy, CCO at Envirotainer, explores how technology, geopolitical tension, and climate change have all contributed to this significant transformation.

Packaging manufacturer Coveris has revealed record sustainability performances across its group as rated by EcoVadis. Signifying a new milestone for the company, following a series of recent EcoVadis assessments, almost 60% of sites within the Coveris Group are covered by a Platinum score, ranking them among the top 1% globally. A further 30% of Coveris’ sites are covered by a Gold medal, placing them in the top 5% of companies assessed by EcoVadis.  Sustainability at Coveris is underpinned by the company’s award-winning No Waste vision and environmental, social and governance (ESG) framework. As part of its ESG commitments, Coveris targets…

Liz Cornish is the senior digital marketing & brand manager for BA Sciences outlines key steps facility teams can take to investigate, remediate, and prevent pharmaceutical contamination. Even well-managed pharmaceutical facilities can face contamination events. Failures in HVAC systems, improper workstation use, or lapses in protective protocols may lead to products that are unsafe or ineffective. The consequences often go beyond batch loss, exposing the organisation to regulatory scrutiny and putting patient safety at risk. A systematic, well-documented response helps limit the impact and restore control. Determine the likely source of contamination  Start by assessing potential sources. Contamination can originate…

Veeva Systems has announced that Merck, known as MSD outside of the United States and Canada, has committed to Veeva Vault CRM. The Vault CRM solution will support MSD as they enter one of the most significant launch periods in the company’s history across a diverse set of new therapeutic areas and modalities. “We are excited to expand our strategic partnership with Veeva by moving to Vault CRM,” said Dave Williams, executive vice president and chief information and digital officer at MSD. “We share a deep commitment to customer success, and Vault CRM will provide MSD the technology foundation to drive commercial…

Antares Vision Group, a technological partner in the digitalisation of products and supply chains for companies and institutions, played a role in the latest phase of an ongoing study by Michigan State University’s The Axia Institute that tests the feasibility of applying RFID technology to streamline pharma traceability throughout the supply chain. For the study’s second phase – the results of which have been published by Axia, part of MSU’s Office of Research and Innovation – Antares Vision Group provided mission-critical serialisation software, and shared its decades of expertise and traceability leadership to help inform and optimise the study’s procedures.   The most…

David Staunton, industry transformation leader at Cognizant Life Science Manufacturing shares how life sciences companies are under immense pressure to deliver new treatments to a global population faster. Surging demand for therapies in areas like cancer, weight loss, and immune disorders is placing enormous pressure on development and manufacturing facilities to be faster and more agile.  Laboratory operations are a critical bottleneck. Many processes in the lab remain manual and siloed, hindering throughput. Common issues like equipment downtime, poor scheduling, and underutilised resources create significant challenges.  Manufacturing teams face similar issues. Manufacturing capacity for in-demand medicines is frequently under pressure,…

Veeva Systems has announced Boehringer Ingelheim is the latest top 20 biopharma to standardise customer data across more than 100 countries with Veeva OpenData and Veeva Network. “Accurate and comprehensive” customer reference data from OpenData will equip Boehringer Ingelheim’s teams with the insights needed to engage healthcare professionals (HCPs) with relevant information, while laying the data foundation to scale AI. “Extending our trusted partnership with Veeva by adopting globally harmonised data will strengthen customer engagement and pave the way for future AI use cases,” said Uday Bose, head of human pharma global customer experience excellence and business steering at Boehringer Ingelheim. “Veeva OpenData and…

Thermo Fisher Scientific has announced the launch of two new electron microscopes that will be unveiled at Microscopy & Microanalysis (M&M) in Salt Lake City, Utah, 27-31 July, each contributing to the democratisation of research in the sciences.  Scios 3 FIB-SEM offers high-powered versatility   The Thermo Scientific Scios 3 is a focused ion beam (FIB) scanning electron microscope (SEM) with automation to dramatically improve site-specific quality control. The Scios 3 FIB-SEM offers increased productivity for both industry and academia with enhanced lamella preparation, due to advances in FIB column performance. Ease-of-use upgrades will benefit microscopists of all experience levels.   “Researchers across the…

Anton Paar uses IDS Imaging’s uEye Warp10 camera in its image analysis systems to capture and analyse particle size and shape in real time. Precise material analysis plays a central role in many industries. Whether for quality assurance or for predicting material behaviour, the precise characterisation of particles is crucial. Development laboratories, materials research institutes and testing facilities are confronted with a variety of challenges: Particles can vary widely in form and origin – be it powder, liquid, tablet, sand, microplastic or pigment. In order to analyse this diversity, laboratories have to master a balancing act between precision, efficiency and…

Stevanato Group, a provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, has secured €200 million in financing through agreements with BNL BNP Paribas, Cassa Depositi e Prestiti (CDP), and Banco BPM. These fundings are intended to support the Company’s ongoing capital expenditure projects in Cisterna di Latina (Italy) and Fishers (Indiana, U.S.). The financing agreements bolster Stevanato Group’s capacity expansion efforts and the scaling of commercial production to support customers’ growing biologics programs. CDP has committed €50 million to enhance the production of pre-filled syringes and set-up future capacity for ready-to-use (RTU) cartridges at Stevanato Group’s…

Kling Bio, a biotech company developing antibody-based drugs for cancer and infectious diseases, has entered into a collaboration and license option agreement with Sanofi for the discovery of antibodies and epitopes using its B cell immortalisation and screening platform, Kling-Select. Kling-Select is a proprietary, clinically and commercially validated B cell immortalisation platform that has played a pivotal role in the discovery of potent neutralising antibodies. By leveraging patient-derived B cells, Kling-Select enables rapid identification of novel antibodies and conserved viral epitopes, significantly enhancing vaccine and therapeutic design. Utilising function-first screening workflow, Kling-Select uncovers rare and highly effective immune targets, accelerating the development…

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is launching two complementary initiatives to transform pharmacovigilance (PV) in response to growing member demand. A new dedicated AI in Safety & PV Community of Experts (CoE) will explore how to apply AI safely, ethically and effectively within pharmacovigilance workflows. While the Pharmacovigilance Systems & Processes Standards (PS²) project will establish a set of standard solution and integration requirements for PV systems to reduce duplicated effort and foster greater innovation in common PV workflows using AI. The PS² project has sponsorship and resourcing from Novo Nordisk,…

Neil Smith, CPG president, Schneider Electric comments on the importance of the upcoming UK Point of Care manufacturing legislation that came into force today (23rd July 2025). As the UK implements a comprehensive legal framework for decentralised and point-of-care (POC) manufacture of medicines on 23rd July 2025, we are entering a new era of personalised healthcare. This landmark legislation positions the UK not only as a pioneer in patient-specific therapies—but also as a regulatory leader across Europe. By enabling hospitals, clinics, and even ambulances to produce patient-specific treatments in real time, the UK is setting a precedent that could reshape how…

An investment of $1 billion to increase access to innovative antibiotics and high-quality treatment of antimicrobial resistance (AMR), could boost the European Union’s (EU) economy by $88 billion a year, by the year 2050, finds new research from the Center for Global Development. This is a return on investment of 103:1.  The research is behind a new, interactive tool published by the Center for Global Development, which estimates the economic impact of AMR in 122 different countries, under multiple scenarios.    A scenario in which the EU invests $1 billion to increase access to innovative antibiotics and high-quality treatment would see…

Professor Philipp Koellinger, co-founder and CEO of open science startup DeSci Labs, argues that peer review needs urgent reform and that AI can help pharma live up to its ideals. Peer review is the core quality control mechanism of pharmaceutical research, determining what findings are published and what projects are funded. Yet, the system is surprisingly outdated and inefficient. Journal editors, including in pharmaceutical research face mounting pressure to find the right reviewers, but often rely on outdated tools or author-supplied information that can be biased. The result is a process that struggles with inefficiency, inconsistency and a lack of…

Meech International has introduced the 906 Hyperion 24V Power Supply Unit (PSU), a compact, high-voltage AC power supply with 24VDC input developed to support static management equipment across a wide range of industrial settings, especially useful for pharmaceutical manufacturers. The 906 PSU replaces Meech’s existing 904 and 905 AC power units, delivering new smart features and more reliable performance in challenging factory conditions. Static control Static electricity poses several critical risks in pharmaceutical manufacturing, where even minor contamination can compromise health and safety, and yields. Static increases contamination risks by attracting dust, particles or microbes compromising sterility. Fine, dry powders…

Adrian Tombling, partner and patent attorney, Withers & Rogers explores the future of GenAI and drug discovery. The role of AI in drug discovery is well established, particularly when it comes to accelerating research activity and improving the chances of success in developing an effective therapy. However, recent technological advances are bringing new challenges for pharmaceutical and biotech companies, and in some areas is requiring a change in approach. Whilst there are virtually no drugs on the market that have been badged ‘discovered by AI’, the reality is that many drugs currently in clinical trials have, at least in part,…

Neuraxpharm, a European specialty pharmaceutical company dedicated to central nervous system (CNS) disorders, and Dizlin Pharmaceuticals, a Swedish R&D company focused on late-stage Parkinson’s disease (PD), has announced a strategic global co-development agreement for Infudopa SubC.   Infudopa SubC is a next-generation, wearable drug-device therapy that is designed to offer a user-friendly, flexible, and physiologically sound alternative to existing advanced Parkinson’s treatments. This agreement marks a pivotal milestone for Neuraxpharm as it enters the drug-device space with its first-ever combination therapy, reinforcing its commitment to pioneering innovation in CNS and addressing some of the most pressing unmet needs in neurological care. PD is the fastest-growing neurological…

The UK government has announced a new Life Sciences Sector Plan aimed at strengthening the economy and modernising the NHS, marking a significant step in its wider Industrial Strategy. The plan, launched on 16 July, outlines a ten-year vision to turn Britain’s scientific strengths into tangible health and economic benefits. With the sector valued at around £100 billion and supporting 300,000 jobs across the UK, the government is now doubling down on its potential. The new roadmap promises faster access to treatments, breakthroughs in medical technology, and a shift toward a more preventative, data-led healthcare system. At the heart of the…

Xeltis, a developer of transformative implants that enable the natural creation of living and long-lasting vessels, has announced encouraging preliminary data for Xabg, its coronary artery bypass conduit (CABG), demonstrating positive safety and patency among patients with multi-vessel atherosclerotic coronary artery disease. Xabg is a novel, biorestorative, polymeric conduit which enables continued blood flow in coronary artery disease patients. Developed using Xeltis’ proprietary Endogenous Tissue Restoration (ETR) platform based on Nobel Prize winning polymer technology, Xabg has unique regenerative properties, enabling living tissue to replace it over time. Cardiovascular disease is the leading cause of mortality globally, with coronary artery bypass…

The SciY business has announced the integration of Optimal Industrial Technologies and Optimal Industrial Automation into the SciY Laboratory Digitalization Suite, creating a single, vendor-agnostic software and automation platform that connects molecular research and development, quality control labs, and full-scale biopharma and specialty chemicals manufacturing environments. This integration and unified branding bring together Optimal’s industry-leading synTQ Process Analytical Technology (PAT) Knowledge Management software platform with its proven automation solutions, enabling life scientists and chemical engineers to benefit from streamlined, scalable workflows that supports the entire molecular and materials product lifecycle from early lab discovery experimentation to QC and commercial molecular or…

West Pharmaceutical Services, a specialist in innovative solutions for injectable drug administration, announced that it opened a new purpose-built analytical laboratory building near its manufacturing site in Stolberg. “We are excited to announce the opening of our new, state of the art, laboratory, which will allow us to broaden our range of services to meet the growing needs of our customers for analytical chemistry and microbiological testing,” expressed Kathy dePadua, senior vice president, chief quality and regulatory officer at West. “As a market leader, West recognises the importance of staying agile in response to the continuously evolving regulatory landscape in our…

New environmental regulations and increasing consumer demand for corporate sustainability drive European pharmaceutical companies to commit to green chemistry processes. Ellie Gabel, associate editor for Revolutionized discusses. Scaling up ecologically sound principles is no longer an option but a strategic priority to reduce waste, energy, and harmful substances during medicine manufacturing. Current state of green chemistry adoption in European pharma  Green chemistry adoption is growing exponentially, with over 60 known instances of pharmaceutical entities implementing it in research and manufacturing. The shift toward sustainable drug design and development aims to reduce or eradicate toxic chemicals, focusing on ecological safety and efficiency.…

Arca BioLogistics, a specialist in Life Science logistics, has recently concluded on a development update of its logistics management portal Arca Live.   Designed to give customers total visibility and control over every shipment from collection through to delivery, Arca Live has been developed specifically for the Life Science sector, helping to simplify the entire logistics process from start to finish.   With the ability to create shipments, track progress in real time, monitor GPS and temperature data, access documentation, and manage compliance – all in one central, intuitive platform – the portal is redefining how research professionals and scientists manage their…

One Biosciences, a precision oncology biotech company pioneering clinical grade single-cell tumour transcriptomic profiling, has announced a €15 million Series A financing led by Redmile Group and Blast, with participation from Galion.exe, Invus, Adamed Technology, Sofinnova Partners, Polytechnique Ventures, and Kima Ventures. This round brings One Biosciences’ total funding, to date, to over €20 million including Home Biosciences’ seed financing. One Biosciences technology creates detailed functional profiles of patient tumours, unlocking insights that may drive better clinical decision-making, patient selection, therapy development, and potentially optimising clinical trials. Proceeds from the financing will accelerate the clinical development of One Biosciences’ flagship…

Numan, a UK digital health provider, has announced that it has raised $60 million in fresh funding, following another year of growth.  The latest financing is an extension of Numan’s Series B round. It comprises a new $30 million equity investment led by Big Pi Ventures, known for investing in companies developing exceptional technologies to improve lives and transform industries. Big Pi Ventures is investing through its new Growth Fund strategy. The round was joined by Endeavor Catalyst as well as existing investors: White Star Capital and Novator Partners.  The fundraise also includes access to $27 million in growth capital…

Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, has announced the first results from a collaboration with Insilico Medicine, a clinical-stage biotechnology company driven by generative AI, focused on rentosertib (ISM001-055), a TNIK inhibitor discovered using Insilico’s generative AI approach, in development for the treatment of IPF. Qureight’s AI-powered analytics technologies are specialised towards interstitial lung diseases such as IPF. The company’s proprietary quantitative HRCT biomarkers are predictive of disease progression and mortality in IPF patients, with the world’s largest biorepository of IPF patient data housed on the Qureight platform. The collaboration first harnessed…

For too long, regulatory teams have become bogged down by protracted reviews of the regulatory implications of each new product change, with potential risk to drug availability until these have been assessed and actions set in motion. Now Generative AI (GenAI) promises to change all that, say independent consultant Preeya Beczek and Agnes Cwienczek of ArisGlobal.  Critical in ensuring ongoing product quality, safety and efficacy, assessing the regulatory impact of any change to a medicinal product or its manufacture is also essential to maintain compliance with regulations and manage risk. This applies to every market and regulatory jurisdiction.   The process…

Antares Vision Group, a specialist in the digitalisation and traceability of products and supply chains for companies and institutions, has announced a strategic partnership with LedgerDomain, a specialist in secure digital identity and credentialing for the healthcare supply chain. This collaboration further strengthens the award-winning Verification Router Service (VRS) solution delivered by rfxcel, a business unit of Antares Vision Group, and sets the stage for interoperable messaging across the U.S. pharmaceutical supply chain. DSCSA stakeholders will be invited to learn more in an upcoming webinar on LinkedIn in August.  The partnership enables seamless integration of an OCI-compliant credential into the…

PSI CRO explores solid site relationships and how they are the backbone of successful clinical trials. Without happy, supported sites, enrolment simply cannot happen predictably or within budgetary constraints.  This task has only grown more complex in recent years. While historic challenges like staffing shortages, trial complexity, and issues related to site startup have intensified, they are now joined by the need to often learn and implement new technologies with little support and training.  This article will discuss the common challenges that impact sites’ efficiency and how strategic investment in building long-lasting site relationships benefits sponsors and sites alike.   Site relationship…

DHL Supply Chain announces the opening of a new multi-user facility in Dublin, as part of the €637 million investment into the UK & Ireland region. The site is optimised for customers in the technology, life sciences and healthcare sectors, and delivers a range of specialist services.  These sectors are growing at pace, with a strong presence in Ireland which is host to 9 of the top 10 global software companies and 20 of the top 25 pharmaceutical companies in the world. The new Dublin-based site leverages DHL’s specialist services to directly address the unique needs of businesses in these…

OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, has been named a Gold Winner in the 2025 Merit Awards for Business in the Research and Development category. Presented annually by the Merit Awards, this program celebrates the world’s most innovative companies and individuals driving measurable progress across industries. OncoHost was selected for its R&D work powering the PROphet platform – an AI-driven proteomics solution that analyses the patient’s plasma proteome using bioinformatics and machine learning to deliver both predictive power and biological explainability. “Earning the Gold in Research & Development from the Merit Awards is a meaningful validation of the bold scientific work being done…

Aenova has now introduced a new hot melt extrusion platform at its Regensburg site. This twin-screw extrusion platform is ready to be used in producing amorphous solid dispersions (ASD) for APIs up to OEB 5. Unlocking the full potential of drug candidates Approximately 80% of preclinical drug candidates face bioavailability limitations due to poor aqueous solubility and slow absorption in the gastrointestinal tract. These issues can delay clinical development and hinder the delivery of life-changing therapies to patients. Aenova’s science-driven formulation strategies, including hot melt extrusion and spray drying for amorphous solid dispersions (ASDs), are designed to overcome these barriers…

In the face of volatile energy pricing and grid instability, Aggreko is highlighting the potential for battery energy storage systems (BESS) and battery hybrids to help increase resilience and on-site efficiency. At present, the UK manufacturing sector is being squeezed by some of the highest industrial energy costs across Europe, with prices in the UK 50% higher than those in Germany or France, and four times higher than in the US. Further to this, trade body Make UK recently published a report, Tackling Electricity Prices for Manufacturers, which sets out a costed plan to restore competitiveness and unlock manufacturing growth. The…

The Institution of Chemical Engineers, alongside the Chemical Industries Association, the Royal Society of Chemistry and the Society of Chemical Industry, have written to the Chancellor, the Secretary of State for Business and Trade, and the Secretary of State for Education, committing to work with the government to help implement the industrial strategy, and call on the government to make the most of the opportunities presented in the upcoming Post-16 Skills white paper.  As organisations committed to a sustainable future for UK industry underpinning growth and prosperity for all, the CIA, IChemE, RSC and SCI welcome the Industrial Strategy and…

Fluid control specialist Bürkert has become an official Siemens Product Partner for Siemen’s SIMATIC Automation Systems. The new partnership will extend integration capabilities for OEMs and end users with a focus on valve islands for process industries. Following decades of partnership between the German brands, the new agreement means Bürkert hardware and software is fully integrated within the Siemen’s SIMATIC ecosystem. The partnership enables closer design integration between Bürkert’s valve islands, featuring an assembly of multiple valves in a compact unit with shared communication, and Siemens remote I/O systems. Compatibility in hardware, software, and communications integration will achieve simplified and…

Cellular Origins, a TTP company, focused on efficient robotic manufacture of cell and gene therapies (CGTs), the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, and Resolution Therapeutics, a clinical-stage biopharmaceutical company, have announced the formation of a consortium. The consortium has been awarded a cross-industry Smart Grant of £1 million from Innovate UK, UK’s national innovation agency. The project aims to use novel technologies to deliver, for the first time internationally, a globally-unique, hyper-efficient, fully automated, scalable cell therapy manufacturing platform. The project commenced on 1st July 2025,…

Aptar CSP Technologies, part of AptarGroup, has developed a dual-active material science technology engineered to simultaneously control moisture and oxygen. This technology is designed to provide a singular solution to address these degradation drivers for pharmaceutical drugs, including oral solid dose glucagon-like peptide-1 (GLP-1), medical devices and more.   This new solution marks a significant material science breakthrough in the pharmaceutical industry, extending Aptar CSP Technologies’ 3-Phase Activ-Polymer technology into new use cases where a combination of humidity and oxidation can compromise the efficacy, safety, and shelf life of sensitive oral solid dose drugs, medical devices, implantable mesh devices, microarray patches and…

PSI, a global Contract Research Organisation, explains why selecting a global safety database is one of the most critical decisions in managing clinical trial data. A well-designed safety database is essential for capturing, managing, and reporting safety information, which ultimately supports regulatory compliance and helps protect patient well-being. As trials grow more complex and regulations evolve, the right database solution can improve data integrity, streamline processes, and reduce the risk of delays.  What to look for in a safety database  A comprehensive safety database must, at a minimum, meet regulatory, technical, and operational requirements. On the regulatory side, it should…

IMCD Group, a specialist in the distribution and formulation of speciality chemicals and ingredients, announces the official opening of its newly reorganised and expanded Life Science Laboratory hub in Shanghai. This investment highlights IMCD’s continued commitment to innovation expertise, technical excellence, and collaborative partnerships in China and the broader Asia-Pacific region. The newly inaugurated Life Science Laboratory hub is dedicated to supporting life science industries with newly established or upgraded laboratories for Beauty & Personal Care, Pharmaceuticals, and Food & Nutrition. The hub brings together the three laboratories to increase cross-industry exchanges and enhance our offerings to our customers and partners. The compound is…

Mark Fish, VP and GM of Digital Lab Solutions, Thermo Fisher discusses the importance of making automation more accessible for labs across industries with the next generation of innovation. What specific routine tasks are most targeted for automation in current lab environments?  It’s an unfortunate truth, confirmed through a lot of research, that scientists spend a lot of time on activities that are not helping drive their scientific or business outcomes. This includes repetitive manual laboratory processes like pipetting, weighing or preparing samples, transcription and checking of records from paper to computer systems, searching for and wrangling data for reports and…

Almac Clinical Services, part of the Almac Group, has completed a multi-million-pound investment to enhance cold chain capabilities at its global headquarters in Craigavon, Northern Ireland.  This strategic investment includes the completion of a purpose-built Ultra-Low Temperature facility which has tripled Almac Clinical Services’ -15°C to -25°C secondary packaging capabilities and doubled ultra-low temperature storage capacity (-60°C to -80°C) in Craigavon.    This investment is part of Almac’s global ongoing programme to expand Ultra-Low capabilities, including North Carolina and Singapore facilities which have already been completed.  Almac has also expanded its cold chain packaging capabilities and increased capacity by more than…

Teknomek has added the Hupfer Easy Rider shelving system to its product portfolio, designed to solve one of the biggest challenges for organisations working in the pharmaceutical, healthcare or SSD sectors: lack of storage space. Teknomek, known as a UK’s manufacturers of hygienic furniture and equipment, recently became the UK distributor of Hupfer equipment.  Typically, half of any storage room is taken up by access space, because fixed walkways are needed between shelving racks to allow staff members to reach the shelves. The Easy Rider system takes away this need for fixed walkways, using mobile shelving racks housed on ball-bearing runners. Operatives simply slide…

Mettler-Toledo Product Inspection, a specialist in precision instruments and inspection solutions, will be exhibiting at PPMA Total Show 2025 from 23rd–25th September at the NEC Birmingham, showcasing a range of contamination detection and compliance technologies.   Under the banner Inspect. Protect. Comply, the company will highlight its proven solutions that help food and pharmaceutical manufacturers inspect every product with confidence, protect their brand and productivity and comply with industry standards. Three advanced systems will be demonstrated live on Stand C84, supporting quality control, waste reduction and operational efficiency.  Live demonstrations will feature:  X52 X-ray Inspection System  Offering precise, complete and ultimate…

Ellen Varelas, founder & CEO of LectureLinx, a global provider of innovative compliance technology and services solutions for the biopharmaceutical industry discusses the importance of compliance in the pharma industry. Only a few years ago, compliance was the undisputed top priority in the pharmaceutical industry – regardless of cost. Companies operated under the principle that regulatory adherence was paramount, sparing no expense to ensure robust compliance programs.   But today, the landscape has shifted dramatically. Now, organisations are asking a new question: “How can we maintain compliance while aggressively reducing costs?”  And therein lies the collision.  The industry at a crossroads  Last…

Atlas Copco has expanded its oil-free compressor range, including models specifically designed to meet the stringent air purity and reliability demands of pharmaceutical manufacturing environments. The latest additions include the ZR/ZT 30-55 FLX dual-speed rotary tooth compressors, the ZR/ZT 30-50 VSD+ rotary tooth compressors, the robust ZT 200-355 VSD+ and the ZR 200 – 315 VSD STD rotary screw compressors. All of these compressor ranges offer substantial total cost of ownership (TCO) benefits, addressing the specific requirements of industries that demand stringent air purity standards.  The ZR/ZT 30-55 FLX compressors are the first dual-speed oil-free compressors. They achieve “exceptional” efficiency…

Alphalyse, a Danish contract research organisation (CRO) that has developed GMPvalidated liquidchromatography massspectrometry (LCMS) assays for hostcellprotein (HCP) impurity testing in biologic drugs, has announced that Fidelio Capital has acquired a majority stake in the company. Alphalyse’s founders will retain a significant shareholding, establishing an ambitious partnership aimed at expanding capacity, accelerating international growth, and establishing Alphalyse as the global reference in biologic HCP impurity analysis.  Thomas Kofoed, PhD, cofounder & CEO, Alphalyse said: “Demand for precise insights into HCP impurities is growing quickly as biologics pipelines continue to expand. Fidelio’s operational expertise and global network will allow us to increase our…

Rommelag has successfully achieved the “Ready” level certification in Körber’s PAS-X MSI Plug & Produce program. This certification confirms the compatibility of Rommelag’s aseptic filling machines with Körber’s PAS-X MES interface standards, enabling “simplified, faster integration” for pharmaceutical manufacturers. With the PAS-X MSI Plug & Produce program, Körber’s Business Area Pharma offers a standardised approach to connect systems and equipment to its PAS-X MES. Rommelag’s newly certified “Ready” interface helps reduce custom engineering efforts and accelerates time-to-operation for customers looking to integrate Rommelag’s filling machines into digital manufacturing environments running PAS-X MES. “This certification is a very useful step towards…

PHARMASEAL, provider of the Engility Trial Management Platform consisting of a Clinical Trial Management System (CTMS) CTMS and Electronic Trial Master File (eTMF), has announced a Technology Integration Partnership with Viedoc, a specialist in Electronic Data Capture (EDC) and eClinical technologies. This collaboration integrates PHARMASEAL’s advanced CTMS platform with Viedoc’s EDC capabilities, including its flagship product Viedoc Clinic, to deliver a more integrated solution for life science companies managing clinical trials worldwide.  Together, PHARMASEAL and Viedoc offer life sciences organisations a unified, cloud-based ecosystem to simplify trial oversight, accelerate study timelines, and improve data quality while ensuring regulatory compliance and operational…

Sulzer has announced the launch of its new Scaba STA vertical agitator, a solution designed to deliver “excellent” reliability, sustainability, and total cost of ownership for industrial mixing applications. Building on decades of application expertise the Scaba STA agitator marks a strategic evolution in Sulzer’s portfolio, harmonising the best design features of the renowned SALOMIX and Scaba platforms into a single, high-performance vertical agitator. The hydraulic upgrade, combined with lower design costs, provides added customer value in the form of significant energy savings. Designed for the needs of process engineers and decision-makers who demand operational excellence, Scaba STA sets a new benchmark…

Martyn Williams, managing director of COPA-DATA UK discusses digitalisation of pharma and what’s holding firms back. If you’re working in the office today, look around. Peer over your laptop. How many of your colleagues are still clinging to paper-based processes? Clutching SOPs, annotating batch records, copying notes by hand?  It’s not a dig. It’s a reflection of where the pharmaceutical industry still finds itself in 2025.  According to a 2025 survey by the Pistoia Alliance, more than half of life sciences professionals say internal resistance to change is the number one barrier to transformation.  I’ve seen it too – in…

Temperature-controlled packaging specialist Hydropac has announced the appointment of Kimon Konakoglou as head of research & development, to support the company’s continued expansion of capabilities in the fast-growing pharmaceutical logistics sector.  The move comes at a critical time for the pharmaceutical cold chain, with rising global demand for temperature-sensitive biologics, vaccines, and personalised medicines placing new pressures on packaging suppliers to deliver precise, reliable, and sustainable solutions.   Hydropac is responding to this shift with significant investment in its people, product innovation, and operational infrastructure.  Kimon boasts a Masters in Material Science and Engineering and was selected by Hydropac for his…

Kashmik Formulation, a pharmaceutical manufacturing company headquartered in Ahmedabad, has announced expansion plans aimed at increasing production capacity enhancing operational efficiencies through automation. The company has also set an ambitious revenue target of ₹100 crore for the financial year 2025–26, following a 100% year-on-year growth from ₹20 crore to ₹40 crore in FY24–25. Currently operating at full capacity with a daily output of 1 crore tablets, the company is planning to undertake a 50% capacity enhancement to scale up production to 1.5 crore tablets per day. An investment of approximately ₹20 crore will be allocated towards this expansion, with infrastructure development…

Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, has announced the results of a new study detailing an improved approach to ranking virtual cell models for gene discovery. The research describes the introduction of new metrics and baselines to assess model performance, providing an improved framework for development of more powerful virtual cell models. The new ranking system will also enable Shift to accelerate its rejuvenation target discovery pipeline. Virtual cell models trained using single-cell RNA (scRNA) datasets offer a powerful solution for large-scale screening of phenotypic changes brought…

Nick Petschek, Kotter International discusses how market turbulence is taking a toll on the pharmaceutical industry. Shifting U.S. economic policy is stalling large pharma and biotech deals, causing leaders to push them down the line by months, if not whole quarters. Now more than ever, amid volatile and fast-changing market conditions, pharma leaders and their teams must be capable of swift and effective decision making — to identify and assess emerging opportunities and to pivot their strategy when market conditions demand it.  This is easier said than done. Accelerating decision-making means acting authoritatively without forfeiting the essential balance between risk…

PharmaForceIQ has announced a period of significant growth as it goes beyond omnichannel to optichannel campaign solutions. The company is the fastest growing independent provider of precision customer engagement technologies for the Life Science industry, and it has experienced a multifold increase in average contract value in the past year. In one client, the company expanded from a pilot campaign for one specialty brand to their entire specialty pharmaceutical portfolio in only 7 months. PharmaForceIQ also has a 100% client renewal rate – demonstrating that its data-driven strategies deliver unmatched efficiency and tangible results. Now, the company is moving beyond omnichannel…

India is the largest supplier of generic medicines globally, accounting for one in five generic drugs sold worldwide, and has earned the title “pharmacy of the world”. Dr. Jayashree Aiyar, chief scientific officer, Syngene International discusses. Building on this legacy of large-scale generic supply, India is now advancing into more complex areas of the pharmaceutical value chain, including drug discovery, development, and advanced manufacturing of complex biologics and advanced therapies.  A key driver of this evolution is India’s rapidly growing Contract Research, Development, and Manufacturing Organisation (CRDMO) sector. While it currently accounts for just 2 to 3% of a $140…

Vetter, a global Contract Development and Manufacturing Organisation (CDMO), celebrated the start of construction for its new clinical manufacturing site in Des Plaines with an official groundbreaking ceremony on 26th June. The independent pharmaceutical service provider received the building permit for the new site in April of this year. With an investment of approximately $285 million, this new facility underscores Vetter’s dedication to delivering high-quality services and drug products during early clinical development. “In the current economic climate, it is a positive sign to see an international company like Vetter making a significant investment to expand their footprint here in the…

Charmaine Gadua, manager, Central Marcom and Sustainability Ambassador, Ansell, discusses the urgency of climate action. The urgency of climate action has never been greater, and businesses play a crucial role in achieving global sustainability goals. In alignment with The Paris Agreement, businesses must make a concerted efforts to limit global warming and reduce carbon emissions. A key component of this effort is addressing Scope 1 emissions – those directly produced by a company’s operations – along with Scope 2 emissions. These are indirect emissions from purchased electricity, steam, heating, and cooling. Sustainable supply chain management is no longer optional. It’s…

After Cellular Origins announced its latest collaboration with Johnson & Johnson, Olivia Friett spoke to Edwin Stone, CEO, Cellular Origins about the collab and the future of mobile robotics. What led Johnson & Johnson to selecting Cellular Origins for this collaboration? Our interactions with cell and gene therapy developers consistently highlight a key advantage of Cellular Origins: our technology adapts seamlessly to existing therapeutic workflows without requiring early-stage process modifications. Developers have shared that this flexibility significantly enhances manufacturing efficiency, reduces facility footprint and labour demands, and delivers clear commercial and technological value; factors which resonate strongly across the industry…

Speaking at the Medicines for Europe Annual Conference, Michal Nitka, SVP head generics Europe & global head OTC at Teva Pharmaceuticals, highlights the essential role of a resilient, competitive, and environmentally sustainable pharmaceutical industry in safeguarding patient access to medicines and strengthening Europe’s healthcare sovereignty. While advancing its innovative portfolio of medicines, Teva strongly believes in the vital role that generics and biosimilars play in supporting millions of patients across Europe. “A strong, competitive, and sustainable pharmaceutical sector is vital not just for economic growth, but to protect patients across Europe,” said Nitka. “Producing in Europe, means building a secure, future-ready healthcare…

ProFound Therapeutics has announced a four-year collaboration with Novartis to discover and develop novel therapeutics for cardiovascular disease leveraging its ProFoundry Platform. This collaboration aims to bring innovative solutions to a growing population of patients by joining ProFound’s unique capabilities in the identification of novel proteins from the expanded proteome as drugs and drug targets with Novartis’ exceptional cardiovascular drug development expertise enabled by their longstanding commitment to helping people with cardiovascular diseases. The ProFoundry Platform combines multi-layered sources of biological data with advanced computational tools to uncover, investigate, and validate a rich source of proteins hidden within the expanded human proteome…

Dr Audrey Dubourg, product manager, and Ayisha I. A. Malik, content marketing manager CN Bio, discuss how to effectively adopt and leverage Organ-on-a-chip to drive more effective drug development. The pharmaceutical industry has experienced tremendous growth over the last century, through innovation, technological advancements and globalisation. So, it is surprising that late-stage drug development failures remain high, at approximately 90%. With the advent of advanced drug modalities and more personalised approaches to medicine, innovative New Advanced Methodologies (NAMs), such as Organ-on-a-chip (OOC), are essential for improving drug development efficiency and outcomes.   OOC platforms, also known as microphysiological systems (MPS), condense…

Platinum Press, Inc. (PPI), a provider of printed packaging solutions specialising in labels, folding cartons, leaflets, foil lidding and flexible packaging, has commenced large-scale production runs on two new Rapida 106 X Printing Presses from Koenig & Bauer. Now fully integrated into the company’s recently expanded, 220,000-square-foot facility in Fort Worth, Texas, the perfector presses are among the first two of their kind operating in the United States.   Capable of running a wide variety of materials – from 24# leaflet stock to 32-point carton stock – the Rapida 106 X presses can produce up to 18,000 sheets per hour. To accommodate comparably dense carton printing…

Deborah McElhone, head of sustainability pharma at the Centre for Process Innovation (CPI), discusses the partnership between India and the UK. The UK’s National Health Service (NHS) is targeting net zero with its Scope1, 2 and 3 emissions by 2045. Given the global nature of pharmaceutical supply chains and the fact that 25% of medicines dispensed in the UK are sourced from India, addressing this target requires collaborative efforts on a worldwide scale.  Although India has set ambitious sustainability targets, including commitments to achieve net zero emissions by 2070, these targets do not fully align with NHS ambitions, potentially leading…

Christy Eatmon, global subject matter expert, steriles, Thermo Fisher Scientific explores how to meet the growing demand for prefilled syringes. The pharmaceutical industry has always been resolutely focused on getting safe and effective therapies to patients in need and, with that, meeting a growing demand for therapeutics that are also easy to administer. Healthcare providers and patients alike are seeking more convenient methods to gain the positive outcomes experienced with medications historically delivered via less patient-friendly technologies, particularly those that require very frequent dosage or professional administration. Enabled by technological advancements, innovative drug delivery devices – such as prefilled syringes…

Mario Toubes-Rodrigo, global applications leader, H.E.L Group shares how high pressure bioreactors can transform fermentation for a sustainable tomorrow. The history of using bioreactors for fermentation processes stretches back over 10,000 years, when pottery vessels were used to ferment a mixture of rice, honey, and fruit in China, but it was not until the 1950s that we started to see their use in pharma and biotech. Nowadays, bioprocessing plays a critical role in these industries, with emerging trends such as using sustainable feedstocks and waste byproducts to manufacture valuable and renewable products offering a novel approach to solving global challenges…

Niklas Adamsson, COO at Envirotainer looks at the key considerations when preparing the cold chain for climate change. Global distribution of life-saving pharmaceuticals is incredibly complex, with several different components from warehouse to final delivery. At each stage, providers must make sure strict temperature requirements are met across varying climates and infrastructures.  Here are some key considerations when preparing the cold chain for climate change.  1. Cold chains need to be smarter and stronger  One key consideration is that as weather becomes increasingly volatile, cold chains need to become smarter and stronger. Supply chain disruptions can easily cause issues with…

Aaron Quinn, senior manager – Europe, Vantage Nutrition highlights how V-beads technology is redefining supplement delivery. In recent years, the conversation around nutraceuticals has moved far beyond ingredient lists and recommended daily intakes. Today’s consumer is no longer satisfied with knowing what’s in it, they’re asking how it’s delivered. The delivery system is becoming the critical differentiator in a market increasingly driven by efficacy, bioavailability, and transparency.  Among the emerging solutions, beadlet technology—and specifically V-beads—is redefining intelligent supplementation. By optimising how active ingredients are protected, released, and absorbed, V-beads signal a fundamental shift in how the nutraceutical industry approaches formulation. …

Bionova Scientific, a contract development and manufacturing organisation (CDMO), is entering the advanced therapy manufacturing space. The company is installing its third FlexFactory manufacturing platform from Cytiva, a Danaher company, to help meet the surging demand for advanced therapies, while maintaining their core monoclonal antibody (mAb) business. Bionova will also use Cytiva’s Fast Trak process development services to help advance their entry into genomic medicines. Fabio Fonseca, Ph.D. senior director, pDNA Process Development, Bionova Scientific, said: “Using Cytiva’s end-to-end solutions, we’ll have an exceptional platform to support the manufacture of genomic medicines. Together with our team and technology stack, we are…

Nigel Theobald, CEO, N4 Pharma explores the future of targeted therapeutics with next-generation silica nanoparticle delivery. In the evolving landscape of precision medicine and targeted therapy, success is increasingly determined not only by the efficacy of the drug itself, but also on the precision and reliability of the delivery mechanism employed. Targeted therapeutics, designed to interact with specific cellular pathways or disease sites, necessitate delivery systems that can evade the natural defences and barriers within the body to reach their intended targets without eliciting adverse effects.  The demand for delivery technologies that can safely, precisely and efficiently transport RNA therapeutics…

PCI Pharma Services will use the BIO International Convention, 16-19th June in Boston, as a platform to introduce its new purpose-built facility for large-scale sterile fill-finish operations at its campus in nearby Bedford, NH. At Booth 1979, PCI experts will provide attendees with key updates as the 50,000-square-foot facility approaches full-scale GMP production this summer.    With site construction and infrastructure installation now complete, PCI has commenced qualification activities for the Bedford plant’s Annex 1-compliant sterile fill-finish manufacturing technologies. Among other highlights, the facility houses an aseptic vial fill-finish line within a fully isolated containment system, equipped with twin 430-sq-ft lyophilisers…

IMA has created two new centres of expertise within the organisation: the IMA AI LAB and Embedded Data Machines. Their mission is to consolidate and expand the use of AI across several fronts – from integrating intelligent functionalities into machines and plants, to advanced data collection and analysis, to the development of predictive algorithms and advanced tools for support and technical assistance. Special focus will be given to enhancing advanced troubleshooting through intelligent systems capable of anticipating, diagnosing, and resolving anomalies with increasing speed and precision.  This further development and implementation of AI stems from the consolidation and structuring of…

Aragen, a contract research, development and manufacturing organisation (CRDMO), announced that it will commence GMP manufacturing at its biologics manufacturing facility in Bangalore, India from late July 2025.  Aragen has successfully completed the facility and equipment qualification and demonstrated the productivity of its intensified fed batch cell culture manufacturing platform to deliver titers >25 g/L.  The news, released ahead of BIO Boston, comes on the back of several successful pharma customer audits with more biotech discussions expected to accelerate at the event.  The facility opens with the flexibility to house multiple 2KL Single use Bioreactors, set up for both fed…

Despite its growing threat to global health, research aimed at tackling antimicrobial resistance (AMR) has been constrained for many years, most likely due to the rapid evolution of resistance in pathogens, regulatory and policy barriers, and high research and development (R&D) costs. However, recent developments have led to a growing belief that viable solutions to this pressing global health issue may be within reach. Georgia Mann, senior associate, Withers & Rogers discusses.  The World Health Organisation (WHO) has identified AMR as one of the most serious global health threats. In 2019 alone, bacterial AMR directly caused an estimated 1.27 million deaths and was associated…

Human Data Sciences (HDS), the UK-based medtech company behind the real-world data analytics platform Livingstone, has launched a landmark update to the platform that enables researchers to conduct comparative outcomes studies across multiple endpoints simultaneously. This new capability arrives at a critical time for the life sciences industry, particularly in Europe, where the implementation of the EU Joint Clinical Assessment Regulation (EU HTA) is creating increased demand for rapid comparative effectiveness data to support regulatory decisions. This comparative outcome study update offers a rapid, automated, and scientifically rigorous solution for generating comparative evidence at scale.  “This update introduces a step-change in how comparative outcomes…

Russell Miller, VP, global sales and marketing, Enzene shares how to drive down the cost of monoclonal antibody manufacturing. Monoclonal antibodies (mAbs) have become central to modern biopharmaceutical therapy, with clinical applications spanning oncology, autoimmune diseases, and infectious disorders. Yet despite their clinical significance, mAbs remain expensive to manufacture, posing a persistent barrier to affordability and access, particularly in resource-limited settings.  With biotech companies still struggling to secure funding and capital markets remaining tight, there is a growing imperative to stretch resources and reduce the cost of this promising modality. Rising manufacturing costs, compounded by economic uncertainty and pricing pressures,…

Verista, a provider of automation, compliance, and quality solutions for the pharmaceutical industry, highlights the LABELQ Label & Print Reconciliation System, a platform engineered to transform label management for medical device, pharmaceutical, and contract manufacturers.  LABELQ streamlines operations by integrating print, inspection, and accountability into a single, unified platform, significantly increasing efficiency and reducing operational complexity for small and medium batch production environments.  LABELQ is designed to deliver 100% automatic label inspection with real-time feedback. This inspection capability reduces the risk of product recalls, label mix-ups, and poor label quality, safeguarding both brand reputation and end-customer trust. By automating record…

Olivia Friett recently had the opportunity to attend i-team Global’s immersive launch, in Dublin, of the SAFE-T-product family – a suite of battery-powered floor cleaning solutions designed for cleanrooms. European Pharmaceutical Manufacturer spoke to Ryan McClymonds, global technical director about cleanroom challenges and how these products help to tackle them.  What specific cleanroom challenges do you aim to address with the new SAFE-T range?   The biggest challenge for keeping cleanrooms hygienically clean is labour and time. In the pharmaceutical sector, including in laboratories where stringent contamination control is needed, floor cleaning has relied heavily on manual wiping and mopping. I’ve seen this…

Kivu Bioscience, a biotech company developing next-generation antibody-drug conjugates, has announced a manufacturing partnership with Sterling Pharma Solutions, a global contract development and manufacturing organisation (CDMO), to produce cGMP-quality material for Phase 1 clinical trials of its lead oncology antibody-drug conjugate (ADC) candidate, KIVU-107.  Under the agreement, Sterling will manufacture cGMP clinical material for KIVU-107 at its dedicated bioconjugation facility in Deeside, UK. The collaboration includes process familiarisation, analytical development, process optimisation, and scale-up activities in preparation for a cGMP manufacturing campaign.  “We chose Sterling as our manufacturing partner based on their deep expertise in ADC development, proven track record of…

As we move further into 2025, it’s clear the pharmaceutical manufacturing sector is at a pivotal point. We’re seeing real momentum, in the industry – but also a lot of pressure. Olivia Friett, editor of European Pharmaceutical Manufacturer discusses. COVID-19 exposed just how fragile global supply chains can be, particularly when it comes to sourcing APIs and essential raw materials. In the years since, we’ve seen a clear effort to strengthen local manufacturing and reduce dependence on external suppliers. This hasn’t been an easy journey. It’s about building long-term security, boosting innovation, and ensuring the industry can respond quickly in…

Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), has announced an international collaboration with Thermo Fisher Scientific.  The collaboration will combine Thermo Fisher’s proven cell culture and processing technology and Cellular Origins’ CGT robotic manufacturing platform, Constellation, to deliver full, robotic, 24/7 production of CGTs to the advanced therapy sector at the industrial scale. Both companies aim to achieve the largest production output of CGTs per square metre of manufacturing space, as well as the lowest labour requirements currently available within a digitally integrated framework. The primary aim of the…

The pharmaceutical industry faces significant challenges in its mission to provide safe, effective, and affordable products. Noam Nahari, VP marketing & business development at LOG Pharma Primary Packaging discusses. Achieving this goal is particularly demanding for suppliers to the drug industry, which must consistently meet stringent standards while controlling costs.  Amid this reality, the R&D team at LOG Pharma Primary Packaging, which has been developing innovative packaging solutions for the international pharmaceutical and medical sectors for more than 50 years, was presented with a formidable task several years ago. Pushing boundaries, management asked the team to develop a packaging solution…

Shilpa Biocare, a fully-owned subsidiary of Shilpa Medicare, announces ahead of BIO Boston that it has secured a Europe-wide commercial supply agreement with Orion Corporation for Recombinant Human Albumin. Shilpa’s Recombinant Human Albumin – a key plasma protein used in various therapeutic applications – is currently under development and will be manufactured using a robust non-human expression system. This provides improved safety, scalability, and virus-free production, addressing some of the key limitations associated with human-derived albumin. Under the terms of the agreement, Orion will gain exclusive rights to distribute, market and sell Shilpa’s Recombinant Human Albumin in Europe, with Shilpa receiving development and…

European Pharmaceutical Manufacturer talks to leading companies to see what’s happening at BIO Boston. Hongene – David Butler, CTO  What are you most looking forward to?  At BIO Boston, we’re most looking forward to connecting with partners across the nucleic acid therapeutics ecosystem who share our commitment to advancing the next generation of RNA and oligonucleotide-based medicines. This event offers a unique opportunity to engage with innovators tackling the complexities of nucleic acid manufacturing and to explore collaborations that help accelerate the transition from concept to clinic.  We’re especially eager to discuss how emerging manufacturing methodologies and integrated CDMO capabilities can…

XL-protein has announced that it has entered into a worldwide License, Development and Commercialisation Agreement with Grifols for a long-acting biopharmaceutical product. Under this collaboration, XL-protein will leverage its proprietary, clinical-stage PASylation technology to extend the circulation of Grifols therapeutics, paving the way for a more effective and long-lasting treatment. XL-protein will actively support preclinical development activities while Grifols will be entitled to further developing as well as manufacturing and marketing the PASylated-enhanced biologic. Under the terms of the agreement, XL-protein will receive an upfront payment as well as payments for achievement of preclinical, clinical, regulatory and commercial milestones. Furthermore, XL-protein…

Watson-Marlow Fluid Technology Solutions (WMFTS) has introduced WMArchitect Interchangeable Parts to secure a resilient supply of single-use assemblies by including pre-qualified, alternative components in the design stage to avoid regulatory compliance interruptions and long lead times.   The new service for bioprocessing eliminates the disruption of reduced component stock and potential production shutdowns, to instead enable a simplified way to substitute in suitable components with shorter lead times.   Interchangeable Parts provides qualified, alternative component options in an assembly which are agreed during the design stage. This avoids supply constraints of a specific component, such as tubing, tri-clamps and other tube fittings.  Alongside…

CluePoints, the sponsor of RBQMLive and provider of statistical and AI-driven software solutions, has announced the full agenda and expert speaker line up for the 4th annual RBQMLive. RBQMLive, taking place on Thursday, 25th September, 2025, is a free virtual event, that unites industry experts, clinical trial specialists, and the wider industry to share insights, education and discuss the acceleration of RBQM. The free event will profile discussions on the return on investment of RBQM, the impact of recent regulatory updates and the implementation of AI. Following the success of last year’s event, which drew in over 1,500 attendees from more…

Schneider Electric, a company in the digital transformation of energy management and automation, has announced new data centre solutions specifically engineered to meet the intensive demands of next-generation AI cluster architectures. Evolving its EcoStruxure Data Center Solutions portfolio, Schneider Electric introduced a Prefabricated Modular EcoStruxure Pod Data Center solution that consolidates infrastructure for liquid cooling, high-power busway and high-density NetShelter Racks. In addition, EcoStruxure Rack Solutions incorporate detailed rack configurations and frameworks designed to accelerate High Performance Computing (HPC) and AI data centre deployments. The new EcoStruxure Pod Data Center and EcoStruxure Rack Solutions are now available globally. Organisations are deploying AI clusters and grappling with extreme rack power…

Oxford-based SynaptixBio, which is developing a therapy for a rare, deadly, and currently incurable rare disease (H-ABC), says it has identified the drug it will take forward into clinical trials. The drug, SB H-19642, is an antisense oligonucleotide (ASO), which is a short strand of synthetic DNA that stops mutated genes from producing toxic proteins. The mutated gene is ‘silenced’. Dan Williams PhD, CEO at SynaptixBio, said: “This is a hugely significant milestone. We are confident our candidate drug will deliver the same positive impacts that ASOs have made on other degenerative diseases such as Duchenne muscular dystrophy. “The dangerous proteins produced…

Dr. Werner Engelbrecht, senior director strategy, Veeva Systems explores how this year could see clinical trial innovation surge as EU regulation evolves. Europe’s clinical trial regulations are evolving fast. Policies including the EU General Data Protection Regulation (GDPR), the AI Act, ACT EU and the soon-to-launch European Biotechnology law are redefining clinical trial standards. Biopharma companies must now balance compliance with innovation, navigating a landscape that demands both transparency and technological agility.  In a 2024 address, the European Commission President reinforced the EU’s ambition to lead in life sciences, advocating for more harmonised and innovation-ready regulation. As these reforms unfold,…

Khalil Essani, product line manager sterile products at Single Use Support explains how process intensification advances bioprocessing.  Optimising production processes has become essential in the rapidly changing biopharmaceutical manufacturing market, in order to remain competitive and satisfy needs for healthcare around the world. Traditional bioprocessing techniques frequently struggle with high costs due to inefficiencies and risk reduction measurements, which restricts the availability of essential medications to larger populations.   What makes a bioprocess more intense?  The primary goal of (bio)process intensification is to increase productivity, lower costs, and shorten the time to market to develop and manufacture pharmaceuticals safely and efficiently.…

Cherwell, an Analytichem company, cleanroom microbiology solutions company, has introduced a new range of plated prepared media designed to deliver sample security, data integrity, and optimised workflow in microbial monitoring. Cherwell’s new Redipor TwistLock prepared media plates feature a secure locking lid and side-label with a GS1 DataMatrix barcode to enhance contamination protection, improve traceability and support automation, ensuring environmental monitoring (EM) meets exacting industry standards. The addition of Redipor TwistLock plate options alongside standard plates in Cherwell’s broad range of Redipor prepared media products, supports a shift in pharmaceutical and associated industries towards more standardised, traceable, and risk-based microbial EM. The new locking lid plates…

Alex Guillen, global SME life science & pharma director, Tive explores how real-time visibility is transforming pharmaceutical logistics. The pharmaceutical supply chain is one of the most complex and highly-regulated sectors in the world—and is tasked with safeguarding the integrity of life-critical products ranging from clinical trial materials to innovative gene and cell therapies. As pharma companies continue to grow and diversify their product portfolios, the challenges of managing these shipments have grown even more complex. Whether it’s ensuring products are stored and transported under strict temperature controls, meeting increasingly stringent regulations, or responding swiftly to disruptions, the need for…

Italfarmaco has announced that the European Commission (EC) has granted conditional marketing authorisation for Duvyzat (givinostat), a novel histone deacetylase (HDAC) inhibitor. It is approved for the treatment of Duchenne muscular dystrophy (DMD) in ambulant patients 6 years and older, regardless of the underlying genetic mutation, when taken together with corticosteroids. The EC decision follows the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) on the 25th of April, 2025. The approval applies to all 27 EU member states, as well as Iceland, Liechtenstein, and Norway. Italfarmaco is now working closely with national…

The Apr-Jun 2025 issue of European Pharmaceutical Manufacturer explores the latest sustainability in packaging trends, a Q&A with i-team Global, features on bioprocessing, process technologies and drug delivery, as well as a cover story from Tive. ×  

Lubrizol has expanded their distribution agreement with IMCD to help meet medical solutions demand in the United States and Canada. The collaboration aims to expand a well-established medical TPU-focused partnership in Europe to North America, with IMCD empowered to enhance market penetration, efficiently manage inventory and strengthen customer relationships. Lubrizol has an extensive range of medical grade TPU solutions and differentiated design, development, and manufacturing services for medical devices. IMCD is a leading partner for the distribution and formulation of specialty chemicals and ingredients. The company has developed expertise in medical-grade polymers and established an extensive presence in the medical…

Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, has announced the publication of new research identifying a novel, single-gene target for cellular rejuvenation. Capable of reversing cellular aging across multiple cell types, without inducing dangerous pluripotency pathways seen in other approaches, SB000 is well positioned as a target for safer, next-generation cell rejuvenation therapeutics, with broad application across age-driven diseases. Existing approaches to cell rejuvenation primarily focus on the Yamanaka Factors (OSKM), a combination of genes that can be used to reverse cellular aging but are known to induce…

Within Water for Injection (WFI) loops, the potential for biofilm development is a critical threat that is primarily caused by laminar flow and the presence of dead zones in the pipework. Bürkert’s business development manager for pharma & biotech, Damien Moran, explains. Flow metering and control are crucial to prevent biofilm accumulation, and to achieve this, Surface Acoustic Wave (SAW) technology has significant advantages over traditional methods. Contactless, precision measurement and a straight measuring tube optimise hygiene while maintaining the critical flow rate. As ultra purified water used in the preparation of parenteral drugs, it’s essential for WFI to be free…

PSB Industries, a specialist in the design and fabrication of systems for dehydrating and purifying gasses and liquids, is highlighting its Siloxane Removal packaged skid, an advanced gas purification system. This solution is engineered to meet the rigorous demands of gas processing across diverse industries. The Siloxane Removal packaged skid offers a dependable method for eliminating siloxanes and protecting valuable equipment, making it an essential component for facilities seeking to maintain operational reliability and meet purity standards.  The system features a proprietary sacrificial carbon-based media that removes siloxanes from gas streams at parts-per-million levels down to undetectable concentrations. This high removal…

iOnctura, a clinical-stage biopharmaceutical company, has announced the appointments of Steven Sciuto as chief financial officer (CFO) and Michelle Tsai PharmD as chief operating officer (COO). Catherine Pickering, CEO and co-founder of iOnctura said: “Following our successful initiation of a number of Phase II studies for our lead asset, roginolisib, we are committed to building a world-class Leadership Team that not only delivers on the promise of this asset but also strengthens our entire portfolio. As we enter the next phase of our strategy, every new leader has been carefully chosen for their expertise, vision and ability to drive transformative growth…

Medicines Discovery Catapult (MDC) and the Francis Crick Institute have announced a new strategic partnership to support the delivery of KQ Labs, a national accelerator for data-driven health science start-ups. Founded and hosted by the Crick, the KQ Labs programme is an annual five-month launchpad for up to ten start-ups building science-backed, scalable solutions in drug discovery, digital health, precision medicine, and beyond. KQ Labs helps young companies de-risk their innovation and provides them with expert mentoring and access to high-value industry and investor networks. Since 2018, KQ Labs has supported 70 start-ups across seven cohorts, helping them to transform breakthrough biomedical and data science…

Brenntag has announced the acquisition of mcePharma. The acquisition and additional investments in the site of mcePharma will “strengthen” Brenntag’s capabilities across the pharma and biopharma value chain. The existing GMP facilities, advanced sampling services, and expertise in both OTC product development and GMP powder pack-off will add to the growing portfolio of capabilities and value added services Brenntag Pharma offers principals and customers in the EMEA region. “The integration of GMP blending and down-packing, along with added warehouse and office space, positions us to meet growing demand while ensuring operational excellence. It’s a powerful enhancement to our portfolio that reinforces…

Just when pharmaceutical supply chains had begun to recover from the chaos of the pandemic, companies are now faced with the threat of US tariffs and the ongoing investigation into the United States’ reliance on drug imports. Nick Fryer, vice president of marketing, Sheer Logistics discusses. According to a recent survey, 90% of US biotech companies rely on imported components for at least half of their US Food and Drug Administration (FDA)-approved products. 94% of the survey respondents forecast an increase in manufacturing costs if tariffs are placed on imports from the European Union.    These newer threats to supply chain operations have…

OneChain Immunotherapeutics (OCI), a clinical-stage biotechnology company focused on the development of CAR-T therapies for the treatment of oncologic diseases, has announced the appointment of Barbara Krebs-Pohl as the new chair of the Board of Directors.   Krebs-Pohl has over 27 years of experience, particularly in business strategy and alliance development. She has held key positions at companies, including MorphoSys, where she served as chief business officer, leading strategies that generated $2.9 billion in revenue. Her expertise in strategic partnerships and acquisition integration, notably with Constellation Pharmaceuticals, played a “pivotal role” in strengthening MorphoSys’s oncology leadership, contributing to its recent acquisition…

European Pharmaceutical Manufacturer asks John McDermott, vice president of scientific consulting at Quotient Sciences what the benefits are of using a CRDMO? What are the benefits of using a CRDMO?  CRDMOs offer a number of strategic and operational benefits for pharmaceutical and biotech companies, with the exact benefits dependent upon the nature of the particular CRDMO.  CRDMOs combine the capabilities of CROs (Contract Research Organisations) and CDMOs (Contract Development and Manufacturing Organisations), into a single partner. This integration provides the potential to seamlessly translate development activities between discovery, development, and manufacturing.  By consolidating services under one roof, CRDMOs eliminate the need for…

Enterome SA, a clinical-stage company developing first-in-class OncoMimics immunotherapies to treat cancer, presented new positive data from its ongoing Phase 1/2 “AUDREY” trial of its OncoMimics immunotherapy, EO4010, to treat microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, in Chicago, IL. The poster presentation (Abstract #3536) was given in the poster session Gastrointestinal Cancer—Colorectal and Anal (poster board 205) on 31st May. Pierre Bélichard, chief executive officer of Enterome, said: “These exciting interim clinical data exemplify the strong therapeutic potential of our OncoMimics immunotherapy for cancer. Current treatment options are limited for cancers like MSS/pMMR…

Markus Laubscher, head of pharma at Orbia Fluor & Energy Materials discusses how in the pharmaceutical industry, the stakes are higher than most. We are entrusted not just with commerce but with care – with the lives and well-being of millions of people worldwide.   So when it comes to making sustainable changes to how we operate, especially at the core of our supply chains and product formulations, caution is understandable. But we are fast approaching a moment where hesitation could cost us, not just in patient outcomes but in compliance and competitiveness.   Sustainability in pharma is no longer optional. It’s not a…

FUJIFILM Corporation’s Life Sciences Group companies, a portfolio of businesses offering products, services and comprehensive solutions that span all stages of therapeutic development from discovery through to commercialisation, has announced new names and identities as part of a strategic positioning effort. The Group Companies’ new names, collaborative strategic focus, and structural alignment reflects Fujifilm’s commitment to Life Sciences, offering fully integrated, end-to-end solutions across the drug development lifecycle—from research and discovery to clinical and commercial manufacturing. FUJIFILM Irvine Scientific, headquartered in Santa Ana, California rebrands as FUJIFILM Biosciences under this new structure and strategy. The new name encompasses FUJIFILM Biosciences’…

Europe’s rollout of ISO IDMP product data standards is well underway now, and EMA’s aligned Product Management Services (PMS) platform, now live, is the next priority – with deadlines for enriching existing data hitting from the end of this year. MAIN5’s Michiel Stam walks though the emerging implications for pharma companies.  The rewards for investments in compliance with the ISO Identification of Medicinal Products (IDMP) data standards will start to come into view soon, in Europe at least – enabled by EMA’s planned rollout of Product Management Services (PMS). All of the extensive (and ongoing) foundational work on vocabulary standardisation…